<SEC-DOCUMENT>0001607062-21-000528.txt : 20211112
<SEC-HEADER>0001607062-21-000528.hdr.sgml : 20211112
<ACCEPTANCE-DATETIME>20211112172459
ACCESSION NUMBER:		0001607062-21-000528
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20211108
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211112
DATE AS OF CHANGE:		20211112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SOCIETY PASS INCORPORATED.
		CENTRAL INDEX KEY:			0001817511
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				831019155
		STATE OF INCORPORATION:			NV

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41037
		FILM NUMBER:		211404984

	BUSINESS ADDRESS:	
		STREET 1:		30 GONDOLIERS BLUFF
		CITY:			NEWPORT COAST
		STATE:			CA
		ZIP:			92657
		BUSINESS PHONE:		9493009898

	MAIL ADDRESS:	
		STREET 1:		30 GONDOLIERS BLUFF
		CITY:			NEWPORT COAST
		STATE:			CA
		ZIP:			92657
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sopa111021form8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SOPA="http://thesocietypass.com/20211108">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_SOPA_thesocietypass.com_20211108 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20211108_20211108 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001817511 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityCentralIndexKey">0001817511</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sopa-20211108.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-11-08to2021-11-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001817511</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-08</xbrli:startDate>
        <xbrli:endDate>2021-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_901_edei--DocumentType_c20211108__20211108_zelwmYmaGX5d"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PURSUANT
TO SECTION 13 OR 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>OF
THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported) <b><span id="xdx_907_edei--DocumentPeriodEndDate_c20211108__20211108_zvpCxxN3jgVb"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 8, 2021</ix:nonNumeric></span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_901_edei--EntityRegistrantName_c20211108__20211108_zurIWnSWkGPk"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityRegistrantName">SOCIETY
PASS INCORPORATED</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20211108__20211108_zMN7UVKbQgAh"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityFileNumber_c20211108__20211108_zldkGrMBKFbl"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityFileNumber">001-41037</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20211108__20211108_zRL5sXP2QNac"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityTaxIdentificationNumber">83-1019155</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State
    or other jurisdiction<br />
    of Incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission<br />
    File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS
    Employer<br />
    Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20211108__20211108_zqY3xn17L50j"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityAddressAddressLine1">701
                                            S. Carson Street</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20211108__20211108_zJbBgGmpPWu9"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityAddressCityOrTown_c20211108__20211108_zagSpluKmhJe"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityAddressCityOrTown">Carson
    City</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20211108__20211108_zX5htAcMueM8"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Nevada</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityAddressPostalZipCode_c20211108__20211108_z45GnT6vJtil"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:EntityAddressPostalZipCode">89701</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address
    of registrant&#8217;s principal executive office)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip
    code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>+<span id="xdx_904_edei--CityAreaCode_c20211108__20211108_zUfMJPZUREni"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:CityAreaCode">65</ix:nonNumeric></span>
<span id="xdx_901_edei--LocalPhoneNumber_c20211108__20211108_zbLnuKKleAIl"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:LocalPhoneNumber">6518-9382</ix:nonNumeric></span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--WrittenCommunications_c20211108__20211108_zb0ehmCXFhca"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--SolicitingMaterial_c20211108__20211108_zeOFsZdlJtud"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20211108__20211108_zfCW40m7cy8c"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20211108__20211108_zKKIeRH7cIa9"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading
    symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on which<br />
    registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--Security12bTitle_c20211108__20211108_zxNEpPLCsjz9"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:Security12bTitle">Common
    Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--TradingSymbol_c20211108__20211108_zLLDpiXd1HCj"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" name="dei:TradingSymbol">SOPA</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--SecurityExchangeName_c20211108__20211108_zrAMKRQkG7f"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20211108__20211108_zYvrWCtubosh"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_909_edei--EntityExTransitionPeriod_c20211108__20211108_zMPtX1cmIXZb"><ix:nonNumeric contextRef="From2021-11-08to2021-11-08" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 8, 2021, Society Pass Incorporated (the &#8220;<b>Company</b>&#8221;) entered into an underwriting agreement (the &#8220;<b>Underwriting
Agreement</b>&#8221;) with Maxim Group LLC, acting as representative to the underwriters named on Schedule I thereto (the &#8220;<b>Representative</b>&#8221;),
related to the offering of 2,888,889 shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;<b>Firm Shares</b>&#8221;),
at a public offering price of $9.00 per share. Under the terms of the Underwriting Agreement, the Company has granted the Underwriters
an option, exercisable for 45 days, to purchase up to an additional 433,334 shares of common stock (the &#8220;<b>Option Shares</b>&#8221;)
to cover over-allotments, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Shares were offered and sold by the Company pursuant to the Company&#8217;s registration statement on Form S-1 (File No. 333-258056)
(the &#8220;<b>Registration Statement</b>&#8221;) and filed with the Securities and Exchange Commission (the &#8220;<b>Commission</b>&#8221;)
and the final prospectus filed with the Commission pursuant to Rule 424(b)(4) of the Securities Act of 1933, as amended (the &#8220;<b>Securities
Act</b>&#8221;). The Registration Statement was declared effective by the Commission on November 8, 2021. The closings of the offering
and sale of the Firm Shares and the sale of 236,111 Option Shares occurred on November 12, 2021. Aggregate gross proceeds from the closings
related to the Firm Shares and the Option Shares was $26,000,001 and $2,124,999, respectively. The Company intends to use the net proceeds
from this offering to hire additional employees, including executive officers, software developers, logistics operations staff, sales
and marketing professionals, and for general corporate purposes, including working capital, operating data centers, leasing technology
platforms and sales and marketing activities, as well as funding certain acquisitions of e-commerce companies in the Food &amp; Beverage,
beauty and travel industries in South East Asia and South Asia. The Company is under discussions with a number or potential acquisition
targets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Underwriting Agreement contains customary representations, warranties and covenants by the Company, customary conditions to closing,
indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act, other obligations
of the parties and termination provisions.&#160;The representations, warranties and covenants contained in the Underwriting Agreement
were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement,
and may be subject to limitations agreed upon by the contracting parties. We have also agreed to issue to the Underwriter (or its permitted
assignees) a warrant to purchase 144,445 shares of the common stock, equal to an aggregate of 5.0% of the total number of shares of common
stock sold in this offering (other than pursuant to the over-allotment option) (the &#8220;<b>Representative&#8217;s Warrants</b>&#8221;).
The Representative&#8217;s Warrants will have an exercise price equal to $9.90 (110% of the offering price of the common stock sold in
this offering) and may be exercised on a cashless basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s officers and directors and their affiliates and any holder of 5% or more of the outstanding shares of common stock of
the Company have agreed, subject to certain exceptions, not to offer, issue, sell, contract to sell, encumber, grant any option for the
sale of or otherwise dispose of any shares of our common stock or other securities convertible into or exercisable or exchangeable for
shares of our common stock until and including May 6, 2022 without the prior written consent of the Underwriter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
Underwriting Agreement is filed as <span style="text-decoration: underline">Exhibit 1.1</span> to this Current Report on Form 8-K (this &#8220;<b>Current Report</b>&#8221;) and
the description of the material terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 8, 2021, the Company issued a press release announcing that it had priced the underwritten public offering described in Item
1.01 of this Current Report. The Company&#8217;s press release is filed as Exhibit 99.1 to this Current Report and is incorporated herein
by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 12, 2021, the Company issued a press release announcing that it had closed the underwritten public offering and the exercise
of the over-allotment option for an additional 236,111 shares, each as described in Item 1.01 of this Current Report. The Company&#8217;s
press release is filed as Exhibit 99.2 to this Current Report and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
9.01. Financial Statement and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 89%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex1_1.htm">Underwriting Agreement dated November 8, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex99_1.htm">Press
    Release dated November 8, 2021.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex99_2.htm">Press Release dated November 12, 2021.</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Date:
    November 12, 2021</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>SOCIETY
    PASS INCORPORATED</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/Dennis
    Nguyen</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Dennis
    Nguyen</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZiyZFN91pURGrSBFxG+1Ugm2mTNKqR/KWxhZxGBiG/9//QozEmlamQobzIs/giHVTaY+QY4mM9orBkW62CYSb4804z9r6/v2BKQUGAzMbK3kJQm/tjMMiAaUmKp7ECpRMphLmOxF99ZRsaQq03ugKtC3gwNSwQa/5NSQc9ZMs1a++6oTsDNkQN5aD/IZYqhj21OkH8d1BlqUiGvUTiTVT23xrWuephmWFdehyA/rf6AMG8Uks -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1_1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">









<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-bottom: 0pt; font: bold 12pt/186% Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOCIETY
PASS INCORPORATED</FONT></P>

<P STYLE="margin-bottom: 0pt; font: bold 12pt/186% Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT</B></FONT></P>

<P STYLE="text-align: right; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
8, 202</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAXIM
GROUP LLC</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300
Park Avenue, 16th Floor</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10022</FONT></P>




<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>As
Representative of the Underwriters</I></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>named
on <U>Schedule I</U> hereto</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Society Pass Incorporated, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), hereby confirms its agreement (this
&ldquo;<B>Agreement</B>&rdquo;) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto
(each, an &ldquo;<B>Underwriter</B>&rdquo; and, collectively, the &ldquo;<B>Underwriters</B>;&rdquo;), for whom Maxim Group LLC is acting
as representative (in such capacity, the &ldquo;<B>Representative</B>&rdquo;), (A) an aggregate of 2,888,889 shares of common stock,
(the &ldquo;<B>Firm Shares</B>&rdquo;) par value $0.0001 per share of the Company (&ldquo;<B>Common Stock</B>&rdquo;) and (B) at the
election of the Representative, up to an additional 433,334 shares of Common Stock (the &ldquo;<B>Option Shares</B>&rdquo;, and together
with the Firm Shares, the &ldquo;<B>Shares</B>&rdquo;). The offering and sale of the Shares contemplated by this Agreement is referred
to herein as the &ldquo;<B>Offering</B>&rdquo;.</FONT></P>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Securities; Over-Allotment Option</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Purchase of Firm Shares</U>. On the basis of the
representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company agrees to issue
and sell to the several Underwriters, severally and not jointly, an aggregate of 433,334 Firm Shares at a purchase price of $8.325 per
Firm Share which represents a 7.5% discount to the public offering price per Firm Share (the &ldquo;<B>Purchase Price</B>&rdquo;),</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Underwriters, severally and not jointly, agree to
purchase from the Company the number of Firm Shares set forth opposite their respective names on <U>Schedule I</U> attached hereto and
made a part hereof.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payment and Delivery</U>. Delivery and payment for
the Firm Shares shall be made at 10:00 a.m., New York time, on the second Business Day following the effective date (the &ldquo;<B>Effective
Date</B>&rdquo;) of the Registration Statement (as hereinafter defined) (or the third Business Day following the Effective Date, if the
Registration Statement is declared effective after 4:30 p.m. New York time) or at such earlier time as shall be agreed upon by the Representative
and the Company at the offices of the Representative or at such other place as shall be agreed upon by the Representative and the Company.
The hour and date of delivery and payment for the Firm Shares is called the &ldquo;<B>Closing Date</B>.&rdquo; The closing of the payment
of the purchase price for, and delivery of certificates representing, the Firm Shares is referred to herein as the &ldquo;<B>Closing</B>.&rdquo;
Payment for the Firm Shares shall be made on the Closing Date by wire transfer in Federal (same day) funds upon delivery to you of certificates
(in form and substance satisfactory to the</FONT></P>




<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters)
representing the Firm Shares (or through the full fast transfer facilities of the Depository Trust Company (the &ldquo;<B>DTC</B>&rdquo;))
for the account of the Underwriters. The Firm Shares shall be registered in such name or names and in such authorized denominations as
the Representative may request in writing at least one Business Day prior to the Closing Date. The Company will permit the Representative
to examine and package the Firm Shares for delivery, at least one Business Day prior to the Closing Date. The Company shall not be obligated
to sell or deliver the Firm Shares except upon tender of payment by the Representative for all the Firm Shares.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(d)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Over-allotment Option</U>. For the purposes of covering
any over-allotments in connection with the distribution and sale of the Firm Shares, the Representative on behalf of the Underwriters
are hereby granted an option (the &ldquo;<B>Over-Allotment Option&rdquo;) </B>to purchase up to an additional 433,334 Option Shares.
The purchase price to be paid for the Option Shares subject to the Over-Allotment Option will be equal to $8.325 per Option Share.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(e)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise of Option</U>. The Over-allotment Option
granted pursuant to Section 1(d) hereof may be exercised by the Representative as to all (at any time) or any part (from time to time)
of the Option Shares within 45 days after the Closing Date. The Underwriters will not be under any obligation to purchase any of such
Option Shares prior to the exercise of the Over- allotment Option. The Over-allotment Option granted hereby may be exercised by the giving
of written notice to the Company from the Representative, setting forth the number of Option Shares to be purchased and the date and
time for delivery of and payment for such Option Shares, which will not be later than three Business Days after the date of the notice
or such other time as shall be agreed upon by the Company and the Representative, at the offices of the Representative or at such other
place as shall be agreed upon by the Company and the Representative. If such delivery and payment for all of the Option Shares does not
occur on the Closing Date, the date and time of the closing for such Option Shares will be as set forth in the notice (hereinafter the
&ldquo;<B>Option Closing Date</B>&rdquo;). Upon exercise of the Over-allotment Option, the Company will become obligated to convey to
the Underwriters, and, subject to the terms and conditions set forth herein, the Underwriters will become obligated to purchase, the
number of Option Shares specified in such notice. If any Option Shares are to be purchased, each Underwriter agrees, severally and not
jointly, to purchase the number of Option Shares (subject to such adjustments to eliminate fractional securities as the Representative
may determine) that bears the same proportion to the number of Firm Shares to be purchased as set forth on <U>Schedule </U>I opposite
the name of such Underwriter bears to the total number of Firm Shares.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(f)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payment and Delivery of Option Shares</U>. Payment
for Option Shares shall be made on the Option Closing Date by wire transfer in Federal (same day) funds by deposit of the price for the
Option Shares being purchased to the Company upon delivery to the Underwriters of certificates (in form and substance satisfactory to
the Representative) representing such Option Shares (or through the full fast transfer facilities of DTC) for the account of the Underwriters.
The certificates representing the Option Shares to be delivered will be in such denominations and registered in such names as the Representative
requests not less than one Business Day prior to the Closing Date or the Option Closing Date, as the case may be, and will be made available
to the Representative for inspection, checking and packaging at the aforesaid office of the Company&rsquo;s transfer agent or correspondent
not less than one Business Day prior to the Closing Date or the Option Closing Date, as the case may be.</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(g)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representative&rsquo;s Warrants</U>. The Company
hereby agrees to issue to the Representative (and/or its designees) on the Closing Date, Warrants to purchase 144,445 shares of Common
Stock (the &ldquo;<B>Representative&rsquo;s Warrants</B>&rdquo;). The Representative&rsquo;s Warrants shall be exercisable, in whole
or in part, commencing 180 days from the Effective Date and expiring on the five-year anniversary of the Effective Date at an initial
exercise price of $9.90 per share of Common Stock, which is equal to one hundred and ten percent (110%) of the Offering price of a Firm
Share. The Representative&rsquo;s Warrants and the shares of Common Stock issuable upon exercise of the Representative&rsquo;s Warrants
are hereinafter referred to collectively as the &ldquo;<B>Representative&rsquo;s Securities</B>.&rdquo; The Representative&rsquo;s Securities
and the Shares shall be collectively referred to as the &ldquo;<B>Securities</B>&rdquo;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations and Warranties of the Company</U>.
The Company represents, warrants and covenants to, and agrees with, each of the Underwriters that, as of the date hereof and as of the
Closing Date:</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has prepared and filed with the Securities
and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) a registration statement on Form S-1 (Registration No. 333- 258056), and
amendments thereto, and related preliminary prospectuses for the registration under the Securities Act of 1933, as amended (the &ldquo;<B>Securities
Act</B>&rdquo;), of the Securities which registration statement, as so amended (including post-effective amendments, if any), has been
declared effective by the Commission and copies of which have heretofore been delivered to the Underwriters. The registration statement,
as amended at the time it became effective, <FONT STYLE="letter-spacing: -0.05pt">including the prospectus,</FONT> financial statements,
schedules, exhibits and other information (if any) deemed to be part of the registration statement at the time of effectiveness pursuant
to Rule 430A under the Securities Act, is hereinafter referred to as the &ldquo;<B>Registration Statement</B>.&rdquo; If the Company
has filed or is required pursuant to the terms hereof to file a registration statement pursuant to Rule 462(b) under the Securities Act
registering additional Securities (a &ldquo;<B>Rule 462(b) Registration Statement</B>&rdquo;), then, unless otherwise specified, any
reference herein to the term &ldquo;<B>Registration Statement</B>&rdquo; shall be deemed to include such Rule 462(b) Registration Statement.
Other than a Rule 462(b) Registration Statement, which, if filed, becomes effective upon filing, no other document with respect to the
Registration Statement has heretofore been filed with the Commission. All of the Securities have been registered under the Securities
Act pursuant to the Registration Statement or, if any Rule 462(b) Registration Statement is filed, will be duly registered under the
Securities Act with the filing of such Rule 462(b) Registration Statement. The Company has responded to all requests of the Commission
for additional or supplemental information. Based on communications from the Commission, no stop order suspending the effectiveness of
either the Registration Statement or the Rule 462(b) Registration Statement, if any, has been issued and no proceeding for that purpose
has been initiated or, to the Company&rsquo;s knowledge, threatened by the Commission. The Company, if required by the Securities Act
and the rules and regulations of the Commission (the &ldquo;<B>Rules and Regulations</B>&rdquo;), proposes to file the Prospectus with
the Commission pursuant to Rule 424(b) under the Securities Act (&ldquo;<B>Rule 424(b)</B>&rdquo;). The prospectus, in the form in which
it is to be filed with the Commission pursuant to Rule 424(b), or, if the prospectus is not to be filed with the Commission pursuant
to Rule 424(b), the prospectus in the form included as part of the Registration Statement at the time the Registration Statement became
effective, is hereinafter referred to as the &ldquo;<B>Prospectus</B>,&rdquo; except that if any revised prospectus or prospectus supplement
shall be provided to the Underwriters by the Company for use in connection with the Offering</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">which
differs from the Prospectus (whether or not such revised prospectus or prospectus supplement is required to be filed by the Company pursuant
to Rule 424(b)), the term &ldquo;<B>Prospectus</B>&rdquo; shall also refer to such revised prospectus or prospectus supplement, as the
case may be, from and after the time it is first provided to the Underwriters for such use. Any preliminary prospectus or prospectus
subject to completion included in the Registration Statement or filed with the Commission pursuant to Rule 424 under the Securities Act
is hereafter called a &ldquo;<B>Preliminary Prospectus</B>.&rdquo; Any reference herein to the Registration <FONT STYLE="letter-spacing: -0.05pt">Statement,
any</FONT> Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the exhibits incorporated by reference therein
pursuant to the Rules and Regulations on or <FONT STYLE="letter-spacing: -0.05pt">before the Effective Date</FONT> of the Registration
Statement, the date of such Preliminary Prospectus or the date of the Prospectus, as the case may be. Any reference herein to the terms
&ldquo;amend&rdquo;, &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include: (i) the filing of any document under the Securities Exchange Act
of 1934, as amended, and together with the Rules and Regulations promulgated thereunder (the &ldquo;<B>Exchange Act</B>&rdquo;) after
the Effective Date, the date of such Preliminary Prospectus or the date of the Prospectus, as the case may be, which is incorporated
therein by reference, and (ii) any such document so filed. All references in this <FONT STYLE="letter-spacing: -0.05pt">Agreement</FONT>
to the Registration Statement, the Rule 462(b) Registration Statement, a Preliminary <FONT STYLE="letter-spacing: -0.05pt">Prospectus
and</FONT> the Prospectus, or any amendments or supplements to any of the foregoing, shall be deemed to include any copy thereof filed
with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval System (&ldquo;<B>EDGAR</B>&rdquo;). The Prospectus
delivered to the Underwriters for use in connection with the Offering was or will be identical to the <FONT STYLE="letter-spacing: -0.05pt">electronically
transmitted</FONT> copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T promulgated
by the Commission.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the time of the effectiveness of the Registration
Statement or any Rule 462(b) Registration Statement or the effectiveness of any post-effective amendment to the Registration Statement,
when the Prospectus is first filed with the Commission pursuant to Rule 424(b), when any supplement to or amendment of the Prospectus
is filed with the Commission, when any document filed under the Exchange Act was or is filed, at all other subsequent times until the
completion of the public offer and sale of the Securities, and at the Closing Date, if any, the Registration Statement and the Prospectus
and any amendments thereof and supplements or exhibits thereto complied or will comply in all material respects with the applicable provisions
of the Securities Act, the Exchange Act and the Rules and Regulations, and did not and will not, as of the date of such amendment or
supplement, contain an untrue statement of a material fact and did not and will not, as of the date of such amendment or supplement,
omit to state any material fact required to be stated therein or necessary in order to make the statements therein:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
in the case of the Registration Statement, not misleading, and (ii) in the case of the Prospectus, in light of the circumstances under
which they were made as of its date, not misleading. When any Preliminary Prospectus was first filed with the Commission (whether filed
as part of the registration statement for the registration of the Securities or any amendment thereto or pursuant to Rule 424(a) under
the Securities Act) and when any amendment thereof or supplement thereto was first filed with the Commission, such Preliminary Prospectus
and any amendments thereof and supplements thereto complied in all material respects with the applicable provisions of the Securities
Act, the Exchange Act and the Rules and Regulations and did not contain an untrue statement of a material fact and did not omit to state
any material fact required to be stated therein or necessary in order to make the statements therein, in light</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the circumstances under which they were made, not misleading. No representation and warranty is made in this subsection (b), however,
with respect to any information contained in or omitted from the Registration Statement or the Prospectus or any related Preliminary
Prospectus or any amendment thereof or supplement thereto in reliance upon and in conformity with information furnished in writing to
the Company by or on behalf of any Underwriter through the Representative specifically for use therein. The parties acknowledge and agree
that such information provided by or on behalf of any Underwriter consists solely of: the statements set forth in the &ldquo;Underwriting&rdquo;
section of the Prospectus only insofar as such statements relate to the names and corresponding share amounts set forth in the table
of Underwriters, the amount of selling concession and re-allowance, the over-allotment option, the &ldquo;Underwriting Discount,&rdquo;
&ldquo;Price Stabilization, Short Positions&rdquo; and &ldquo;Electronic Distribution&rdquo; sections and related activities that may
be undertaken by the Underwriters and the paragraph relating to stabilization by the Underwriters (the &ldquo;<B>Underwriters&rsquo;
Information</B>&rdquo;).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither: (i) any Issuer-Represented General Free Writing
Prospectus(es) (as defined below) issued at or prior to the Applicable Time (as defined below) and the Statutory Prospectus (as defined
below), all considered together (collectively, the &ldquo;<B>General Disclosure <FONT STYLE="letter-spacing: -0.05pt">Package</FONT></B><FONT STYLE="letter-spacing: -0.05pt">&rdquo;),
nor (ii) any</FONT> individual Issuer-Represented Limited-Use Free Writing Prospectus(es) (as defined below) when considered together
with the General Disclosure Package, includes or included as of the Applicable Time any untrue statement of a material fact or omits
or omitted as of the Applicable Time to state any material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from any
Statutory Prospectus included in the Registration Statement, the General Disclosure Package or any Issuer- Represented Limited-Use Free
Writing Prospectus (as defined below) in conformity with the Underwriters&rsquo; Information. Each of (i) any electronic road show or
investor presentation (including without limitation any &ldquo;bona fide electronic road show&rdquo; as defined in Rule 433(h)(5) under
the Securities Act) delivered to and approved by the Underwriters for use in connection with the marketing of the Offering as of the
time of their use and at the Closing Date and on each Option Closing Date, if any and (ii) any individual Written Testing-the-Waters
Communication (as defined herein), when considered together with the General Disclosure Package at the Closing Date and on each Option
Closing Date, if any, did not and will not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(d)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Issuer-Represented Free Writing Prospectus, as
of its issue date and at all subsequent times until the Closing Date or until any earlier date that the Company notified or notifies
the Representative as described in the next sentence, did not, does not and will not <FONT STYLE="letter-spacing: -0.05pt">include any
information</FONT> that conflicted, conflicts or will conflict with the information contained in the then-current Registration Statement,
Statutory Prospectus or Prospectus. If at any time following issuance of an Issuer-Represented Free Writing Prospectus there occurred
or occurs an event or development as a result of which such Issuer-Represented Free Writing Prospectus conflicted or would conflict with
the information contained in the then-current Registration Statement, Statutory Prospectus or Prospectus relating to the Securities or
included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances prevailing</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
that subsequent time, not misleading, the Company has notified or will notify promptly the Representative so that any use of such Issuer-Represented
Free Writing Prospectus may cease until it is promptly amended or supplemented by the Company, at its own expense, to eliminate <FONT STYLE="letter-spacing: -0.05pt">or
correct</FONT> such conflict, untrue statement or omission. The preceding two sentences do not apply to statements in or omissions from
any Issuer-Represented Free Writing Prospectus in conformity with the Underwriters&rsquo; Information.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(e)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not distributed and will not distribute
any prospectus or other <FONT STYLE="letter-spacing: -0.05pt">offering material in connection</FONT> with the offering and sale of the
Securities other than the General Disclosure Package, any Issuer-Represented Limited-Use Free Writing Prospectus or the Prospectus or
other materials permitted by the Securities Act to be distributed by the Company. <FONT STYLE="letter-spacing: -0.05pt">Unless</FONT>
the Company obtains the prior consent of the Representative, the Company has not made and will not make any offer relating to the Securities
that would constitute an &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 under the Securities Act, or that would
otherwise constitute a &ldquo;free writing prospectus,&rdquo; as defined in Rule 405 under the Securities Act, required to be filed with
the Commission; provided that the prior written consent of the Representative shall be deemed to have been given in respect of any free
writing prospectus referenced on <U>Schedule II</U> attached hereto. The Company has complied and will comply with the requirements of
Rules 164 and 433 under the Securities Act applicable to any Issuer-Represented Free Writing Prospectus as of its issue date and at all
subsequent times through the Closing Date, including timely filing with the Commission where required, legending and record keeping.
To the extent an electronic road show is used, the Company has satisfied and will satisfy the conditions in Rule 433 under the Securities
Act to avoid a requirement to file with the Commission any electronic road show.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(f)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Representative agrees that, unless it obtains the
prior written consent of the Company, it will not make any offer relating to the Securities that would constitute an Issuer- Represented
Free Writing Prospectus or that would otherwise (without taking into account any approval, authorization, use or reference thereto by
the Company) constitute a &ldquo;free writing prospectus&rdquo; required to be filed by the Company with the Commission or retained by
the Company under Rule 433 of the Securities Act; provided that the prior written consent of the Company hereto shall be deemed to have
been given in respect of any Issuer-Represented General Free Writing Prospectuses referenced on <U>Schedule II</U> attached hereto.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(g)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As used in this Agreement, the terms set forth below
shall have the following meanings:</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(i)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable Time</B>&rdquo; means November
8, 2021, 7:30 p.m. (Eastern time) on the date of this Agreement.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Statutory Prospectus</B>&rdquo; as of any
time means the prospectus that is included in the Registration Statement immediately prior to that time. For purposes of this definition,
information contained in a form of prospectus that is deemed retroactively to be a part of the Registration Statement pursuant to Rule
430A or 430B shall be considered to be included in the Statutory Prospectus as of the actual time that form of prospectus is filed with
the Commission pursuant to Rule 424(b) under the Securities Act.</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer-Represented Free Writing Prospectus</B>&rdquo;
means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 under the Securities Act, relating to the Securities that</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
is required to be filed with the Commission by the Company, or (B) is exempt from filing pursuant to Rule 433(d)(5)(i) under the Securities
Act because it contains a description of the Securities or of the Offering that does not reflect the final terms or pursuant to Rule
433(d)(8)(ii) because it is a &ldquo;bona fide electronic road show,&rdquo; as defined in Rule 433 under the Securities Act, in each
case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&rsquo;s
records pursuant to Rule 433(g) under the Securities Act.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(iv)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer-Represented General Free Writing Prospectus</B>&rdquo;
means any Issuer-Represented Free Writing Prospectus that is intended for general distribution to prospective investors, as evidenced
by its being specified in <U>Schedule II</U> to this Agreement.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(v)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer-Represented Limited-Use Free Writing
Prospectus</B>&rdquo; means any Issuer-Represented Free Writing Prospectus that is not an Issuer-Represented General Free Writing Prospectus.
The term Issuer-Represented Limited-Use Free Writing Prospectus also includes any &ldquo;bona fide electronic road show,&rdquo; as defined
in Rule 433 under the Securities Act, that is made available without restriction pursuant to Rule 433(d)(8)(ii), even though not required
to be filed with the Commission.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(h)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RBSM LLP (the &ldquo;<B>Auditor</B>&rdquo;), whose reports
relating to the Company are included in the Registration Statement, the General Disclosure Package and the Prospectus is an independent
registered public accounting firm as required by the Securities Act, the Exchange Act and the Rules and Regulations and the Public Company
Accounting Oversight Board (the &ldquo;<B>PCAOB</B>&rdquo;). To the Company&rsquo;s knowledge, the Auditor is not in violation of the
auditor independence requirements of the Sarbanes-Oxley Act of 2002, as amended (&ldquo;<B>Sarbanes-Oxley</B>&rdquo;). The Auditor has
not, during the periods covered by the financial statements included in the Registration Statement, the General Disclosure Package and
the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(i)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to the respective dates as of which information
is presented in the Registration Statement, the General Disclosure Package and the Prospectus, and except as disclosed in the Registration
Statement, the General Disclosure Package and the Prospectus: (i) the Company has not declared, paid or made any dividends or other distributions
of any kind on or in respect of its capital stock, and (ii) there has been no material adverse change (or, to <FONT STYLE="letter-spacing: -0.05pt">the
knowledge of</FONT> the Company, any development which would reasonably be expected to result in a material adverse change in the future),
whether or not arising from transactions in the ordinary course of business, in or affecting: (A) the business, condition (financial
or otherwise), results of operations, shareholders&rsquo; equity, properties or prospects of the Company; (B) the long-term debt or capital
stock of the Company; or (C) the Offering or consummation of any of the other transactions contemplated by this Agreement, the Representative
Warrants, the Registration Statement, the General Disclosure Package and the Prospectus (a &ldquo;<B>Material Adverse Change</B>&rdquo;).
Since the date of the latest balance sheet presented in the Registration Statement, the General Disclosure Package and the Prospectus,
the Company has not incurred or undertaken any liabilities or obligations, whether direct or indirect, liquidated or contingent,</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">matured
or unmatured, or entered into any transactions, including any acquisition or disposition of any business or asset, which are material
to the Company, except for liabilities, obligations and transactions which are disclosed in the Registration Statement, the General Disclosure
Package and the Prospectus.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(j)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the dates indicated in the Registration Statement,
the General Disclosure Package and the Prospectus, the authorized, issued and outstanding shares of capital stock of the Company were
as set forth in the Registration Statement, the General Disclosure Package and the Prospectus in the column headed &ldquo;Actual&rdquo;
under the section thereof captioned &ldquo;Capitalization&rdquo; and, after giving effect to the Offering and the other transactions
(excluding the offer and sale of the Option Shares) contemplated by this Agreement, the Registration Statement, the General Disclosure
Package and the Prospectus, will be as set forth in the column headed &ldquo;As Adjusted&rdquo; in such section. All of the issued shares
of capital stock of the Company, including the outstanding Common Stock of the Company, have been duly authorized and validly issued
and are fully paid and nonassessable and have been issued in compliance with all applicable state, federal and securities laws and none
of those shares was issued in violation of any preemptive rights, rights of first refusal or other similar rights to the extent any such
rights were not waived; the Shares have been duly authorized and, when issued and delivered against payment therefore as provided in
this Agreement, will be validly issued, fully paid and non- assessable, and the issuance of the Securities is not subject to any preemptive
rights, rights of first refusal or other similar rights that have not heretofore been waived (with copies of such waivers provided to
the Underwriters); and no holder of any Shares or any shares of Common Stock is or will be subject to personal liability by reason of
being such a holder. The Securities conform to the descriptions thereof contained in the Registration Statement, the General Disclosure
Package and the Prospectus.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(k)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as described in the Registration Statement, the
General Disclosure Package and the Prospectus, (A) there are no outstanding rights (contractual or otherwise), warrants or options to
acquire, or instruments convertible into or exchangeable for, or agreements or understandings with respect to the sale or issuance of,
any shares of capital stock of or other equity interest in the Company or any of its Subsidiaries and (B) there are no contracts, agreements
or understandings between the Company and/or any of its Subsidiaries and any person granting such person the right to require the Company
to file a registration statement under the Securities Act or otherwise register any securities of the Company owned <FONT STYLE="letter-spacing: -0.05pt">or
to be owned</FONT> by such person and any such rights so disclosed have been waived by the holders thereof in connection with this Agreement
and the transactions contemplated hereby including the Offering;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(l)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reserved</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(m)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shares of Common Stock underlying the Representative&rsquo;s
Warrants have been duly authorized and reserved for issuance, conform to the description thereof in the Registration Statement, the General
Disclosure Package and the Prospectus and have been validly reserved for issuance and will, upon exercise of the Representative&rsquo;s
Warrants and payment of the exercise price thereof, be duly and validly issued, fully paid and non-assessable and will not have been
issued in violation of or be subject to preemptive or similar rights to</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subscribe
for or purchase securities of the Company and the holders thereof will not be subject to personal liability by reason of being such holders.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(n)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The subsidiaries of the Company (the &ldquo;<B>Subsidiaries</B>&rdquo;),
together with their respective jurisdictions of incorporation are listed on Schedule IV hereto. Each of the Subsidiaries is directly
or indirectly wholly-owned by the Company and no person or entity has any right to acquire any equity interest in any of the Subsidiaries.
Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company <FONT STYLE="letter-spacing: -0.05pt">holds
no ownership</FONT> or other interest, nominal or beneficial, direct or indirect, in any corporation, partnership, joint venture or other
business</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(o)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and each of its Subsidiaries has been duly
incorporated and <FONT STYLE="letter-spacing: -0.05pt">validly</FONT> exists as a corporation or other entity as the case may be in good
standing under the laws of the jurisdiction of its incorporation and formation. . The Company and each of its Subsidiaries has all requisite
power and authority to carry on its business as it is currently being conducted and as described in the Registration Statement, the General
Disclosure Package and the Prospectus, and to own, lease and operate its properties. The Company and each of its Subsidiaries is duly
qualified to do business and is in good standing as a foreign corporation, partnership or limited liability company in each jurisdiction
in which the character or location of its properties (owned, leased or licensed) or the nature or conduct of its business makes such
qualification necessary, except, in each case, for those failures to be so qualified or in good standing which (individually and in the
aggregate) would not reasonably be expected to have a material adverse effect on: (i) the business, condition (financial or otherwise),
results of operations, shareholders&rsquo; equity, properties or prospects of the Company and its Subsidiaries, considered as a whole;
(ii) the long-term debt or capital stock of the Company; or (iii) the <FONT STYLE="letter-spacing: -0.05pt">Offering or consummation
</FONT>of any of the other transactions contemplated by this Agreement, the Registration Statement, the General Disclosure Package and
the Prospectus (any such effect being a &ldquo;<B>Material Adverse Effect</B>&rdquo;).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(p)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the knowledge of the Company, neither the Company
nor any of its Subsidiaries is: (i) in violation of its organizational documents (ii) in default under any indenture, mortgage, deed
of trust, loan agreement or other agreement or instrument to which it is a party or by which it is bound or to which any of its property
or assets is subject; and no event has occurred which, with notice or lapse of time or both, would constitute a default under <FONT STYLE="letter-spacing: -0.05pt">or
result in the</FONT> creation or imposition of any lien, security interest, charge or other encumbrance <FONT STYLE="letter-spacing: -0.05pt">(a
&ldquo;<B>Lien</B>&rdquo;) upon any of its</FONT> property or assets pursuant to, any indenture, mortgage, deed of trust, loan agreement
or other agreement or instrument to which it is a party or by which it is bound or to which any of its property or assets is subject,
or (iii) in violation in any respect of any law, rule, regulation, ordinance, directive, judgment, decree or order of any judicial, regulatory
or other legal or governmental agency or body, foreign or domestic, except, in the case of subsections (ii) and (iii) above, for such
violations or defaults which (individually or in the aggregate) would not reasonably be expected to have a Material Adverse Effect.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(q)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has full right, power and authority to execute
and deliver this <FONT STYLE="letter-spacing: -0.05pt">Agreement, the Representative&rsquo;s Warrants</FONT> and all other agreements,
documents, certificates and instruments required to be delivered pursuant to this Agreement and the Representative&rsquo;s Warrants.
The Company has duly and validly authorized this Agreement, the Representative&rsquo;s</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">Warrants
and each of the transactions contemplated</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">thereby. This
Agreement has been duly and validly executed and delivered by the Company and constitutes the legal, valid and binding obligations of
the Company and are enforceable against the Company in accordance with their terms, except (i) as such enforceability may be limited
by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally; (ii) as enforceability of any
<FONT STYLE="letter-spacing: -0.05pt">indemnification </FONT>or contribution provision may be limited under federal and state securities
laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable
defenses and to the discretion of the court before which any proceeding therefor may be brought.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(r)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When issued, the Representative&rsquo;s Warrants will
constitute valid and binding obligations of the Company to issue and sell, upon exercise thereof and payment of the respective exercise
prices therefor, the number and type of securities of the Company called for thereby in accordance with the terms thereof and the Representative&rsquo;s
Warrants are enforceable <FONT STYLE="letter-spacing: -0.05pt">against the Company in</FONT> accordance with their respective terms,
except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo;
rights generally; (ii) as enforceability of any indemnification or contribution provision may be limited under foreign, federal and state
securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject
to the equitable <FONT STYLE="letter-spacing: -0.05pt">defenses</FONT> and to the discretion of the court before which any proceeding
therefor may be brought.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(s)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The execution, delivery, and performance by the Company
of this Agreement, <FONT STYLE="letter-spacing: -0.05pt">the Representative&rsquo;s Warrants</FONT> and all other agreements, documents,
certificates and instruments required to be delivered pursuant to this Agreement, and the Representative&rsquo;s Warrants and consummation
of the transactions contemplated hereby and thereby do not and will not: (i) conflict with, require consent under or result in a breach
of any of the terms and provisions of, or constitute a default (or an event which with notice or lapse of time, or both, would constitute
a default) under, or result in the creation or imposition of any Lien upon any property or assets of the Company of any of its Subsidiaries
pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement, instrument, franchise, license or permit to which
the Company or any of its Subsidiaries is a party or by which the Company, any of its Subsidiaries or any of their respective properties,
operations or assets may be bound or (ii) violate or conflict with any provision of the certificate of incorporation, by-laws, or other
organizational documents of the Company or any of its Subsidiaries, or (iii) violate or conflict with any law, rule, regulation, ordinance,
directive, judgment, decree or order of any judicial, regulatory or other legal or governmental agency or body, domestic or foreign applicable
to the Company or any of its Subsidiaries, or (iv) except as disclosed in the Registration Statement, the General Disclosure Package
and the Prospectus, trigger a reset or repricing of any outstanding securities of the Company or any of its Subsidiaries.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(t)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as disclosed in the Registration Statement, the
General Disclosure Package and the Prospectus, the Company and each of its Subsidiaries have all consents, approvals, authorizations,
orders, registrations, qualifications, licenses, filings and permits of, with and from all judicial, regulatory and other legal or governmental
agencies and bodies and all third parties, foreign and domestic (collectively, the &ldquo;<B>Consents</B>&rdquo;), to own, lease and
operate their respective properties and conduct their respective businesses as they are now being conducted and as disclosed in the Registration
Statement, the General Disclosure Package and</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Prospectus, and each such Consent is valid and in full force and effect, except which (individually or in the aggregate), in each such
case, would not reasonably be expected to have <FONT STYLE="letter-spacing: -0.05pt">a Material Adverse</FONT> Effect. Neither the Company
nor any of its Subsidiaries has received notice of any investigation or proceedings which results in or, if decided adversely to the
Company or <FONT STYLE="letter-spacing: -0.05pt">any of its Subsidiaries</FONT> could reasonably be expected to result in, the revocation
of, or imposition of a materially burdensome restriction on, any Consent. No Consent contains a materially burdensome restriction not
adequately disclosed in the Registration Statement, the General Disclosure Package and the Prospectus.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(u)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and each of its Subsidiaries is in compliance
with all applicable laws, rules, regulations, ordinances, directives, judgments, decrees and orders, foreign and domestic, except for
any non-compliance the consequences of which would not have or reasonably be expected to have a Material Adverse Effect.).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(v)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has filed with the Commission a Form 8-A
(File Number 001- 41037) providing for the registration of the Common Stock (the &ldquo;<B>Form 8-A Registration Statement</B>&rdquo;).
The Common Stock is registered pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;). The Form 8-A Registration Statement was declared effective by the Commission on or prior to the date hereof. The Company
has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange
Act, nor has the Company received any notification that the Commission is contemplating terminating such registration;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(w)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Common Stock, including the Shares, has been approved
for listing on the NASDAQ Capital Market, subject to official notice of issuance (the &ldquo;<B>Exchange</B>&rdquo;), and the Company
has taken no action designed to, or likely to have the effect of, delisting the Common Stock from the Exchange, nor has the Company received
any notification that the Exchange is contemplating terminating such listing.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(x)&nbsp;
</FONT>No consent of, with or from any judicial, regulatory or other legal or governmental agency or body or any third party, foreign
or domestic is required for the execution, delivery and performance of this Agreement or the Representative&rsquo;s Warrants or the consummation
of each of the transactions contemplated hereby and thereby, including the issuance, sale and delivery of the Securities to be issued,
sold and delivered hereunder, except (i)&nbsp;such as may have previously been obtained (with copies of such consents provided to the
Underwriters), (ii) the registration under the Securities Act of the Securities, which has become effective, (iii) such consents as may
be required under state securities or blue sky laws or the by-laws and rules of the Nasdaq Capital Market, and (iii) the FINRA in connection
with the <FONT STYLE="letter-spacing: -0.05pt">purchase and distribution</FONT> of the Securities by the Underwriters, each of which has
been obtained and is in full force and effect.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(y)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as disclosed in the Registration Statement, the
General Disclosure Package and the Prospectus, there is no judicial, regulatory, arbitral or other legal or governmental proceeding or
other litigation or arbitration, domestic or foreign, pending to which the Company or any of its Subsidiaries is a party or of which
any property, operations or assets of the Company or any of its Subsidiaries is the subject which, individually or in the aggregate,
if determined adversely to the Company or any of its Subsidiaries would reasonably</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
expected to have a Material Adverse Effect. To the Company&rsquo;s knowledge, except as disclosed in the Registration Statement, the
General Disclosure Package and the Prospectus, no such proceeding, litigation or arbitration is threatened or contemplated and the defense
of any such proceedings, litigation and arbitration against or involving the Company or any of its Subsidiaries would not reasonably
be expected to have a Material Adverse Effect.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(z)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements, including the notes thereto,
and the supporting schedules included in the Registration Statement, the General Disclosure Package and the Prospectus comply in all
material respects with the requirements of the Securities Act and the Exchange Act, and present fairly in all material respects the financial
position as of the dates indicated and the cash flows and results of operations for the periods specified of the Company and its Subsidiaries.
Except as otherwise stated in the Registration Statement, the General Disclosure Package and the Prospectus, said financial statements
have been prepared in accordance with generally accepted accounting principles in the United States (&ldquo;<B>GAAP</B>&rdquo;) applied
on a consistent basis throughout the periods involved, except in the case of unaudited financials which are subject to normal year-end
adjustments and do not contain certain footnotes. The supporting schedules included in the Registration Statement, the General Disclosure
Package and the Prospectus present fairly in all material respects the information required to be stated therein. No other financial
statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the General
Disclosure Package or the Prospectus. The other financial information included in the Registration Statement, the General Disclosure
Package and the Prospectus present fairly in all material respects the information included therein and have been prepared on a basis
consistent with that of the financial statements that are included in the Registration Statement, the General Disclosure Package and
the Prospectus and the books and records of the respective entities presented therein.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(aa)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no pro forma or as adjusted financial statements
which are required to be included in the Registration Statement, the General Disclosure Package and the Prospectus in accordance with
Regulation S-X which have not been included as so required. The pro forma and pro forma as adjusted financial information included in
the Registration Statement, the General Disclosure Package and the Prospectus has been properly compiled and prepared in <FONT STYLE="letter-spacing: -0.05pt">accordance
with the applicable requirements</FONT> of the Securities Act and the Rules and Regulations and include all adjustments necessary to
present fairly in accordance with GAAP the pro forma and as adjusted financial position of the respective entity or entities presented
therein at the respective dates indicated and their cash flows and the results of operations for the respective periods specified. The
assumptions used in preparing the pro forma and pro forma as adjusted financial information included in the Registration Statement, the
General Disclosure Package and the Prospectus provide a reasonable basis for presenting the significant effects directly attributable
to the transactions or events described therein. The related pro forma and pro forma as adjusted adjustments give appropriate effect
to those assumptions; and the pro forma and pro forma as adjusted financial information reflect the proper application of those adjustments
to the corresponding historical financial statement amounts.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(bb)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The statistical, industry-related and market-related
data included in the Registration Statement, the General Disclosure Package and the Prospectus are based on or</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">derived
from sources which the Company reasonably and in good faith believes are reliable and accurate, and such data agree with the sources
from which they are derived.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(cc)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of establishing disclosure
controls and procedures over financial reporting (as defined in Rules 13a-15 and 15d-15 under the Exchange Act) and such controls and
procedures will be designed to ensure that information relating to <FONT STYLE="letter-spacing: -0.05pt">the Company</FONT> required
to be disclosed in the reports that it will file or submit under the Exchange Act will be accumulated and communicated to the Company&rsquo;s
management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(dd)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as disclosed in the Registration Statement, the
General Disclosure Package and the Prospectus, the Company&rsquo;s board of directors has validly appointed an audit committee whose
composition satisfies the requirements of the rules and regulations of the Nasdaq Stock Market and the board of directors and/or audit
committee has adopted a charter that satisfies the requirements of the rules and regulations of the Nasdaq Stock Market. Except as disclosed
in the Registration Statement, the General Disclosure Package and the Prospectus, neither the board of directors nor the audit committee
has been informed, nor is the Company aware, of: (i) any significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely affect the Company&rsquo;s ability to record, process,
summarize and report financial information; or (ii) any fraud, whether or not material, that involves management or other employees who
have a significant role in the Company&rsquo;s internal control over financial reporting.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ee)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any of its Subsidiaries nor
any of their respective Affiliates (as defined in the Securities Act) has taken, directly or indirectly, any action which constitutes
or is designed to cause or result in, or which could reasonably be expected to constitute, cause or result in, the stabilization or manipulation
of the price of any security to facilitate the sale or resale of the Securities.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ff)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any of its Subsidiaries nor
any of their respective Affiliates has, prior to the date hereof, made any offer or sale of any securities which are required to be &ldquo;integrated&rdquo;
pursuant to the Securities Act or the Rules and Regulations with the offer and sale of the Securities pursuant to the Registration Statement.
Except as disclosed in the Registration Statement, the General Disclosure Package, and the Prospectus, neither the Company nor any of
its Affiliates has sold or issued any securities during the six-month period preceding the date of the Prospectus, including but not
limited to any sales pursuant to Rule 144A or Regulation D or Regulation S under the Securities Act.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(gg)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the knowledge of the Company, all information contained
in the questionnaires completed by each of the Company&rsquo;s officers and directors and 5% holders immediately prior to the Offering
and provided to the Representative as well as the biographies of such officers and directors in the Registration Statement are true and
correct in all material respects and the Company has not become aware of any information which would cause the information disclosed
in the questionnaires completed by the directors and officers to become inaccurate and incorrect.</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(hh)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the knowledge of the Company, no director or officer
of the Company is subject to any non-competition agreement or non-solicitation agreement with any current employer or prior employer
which could materially affect his ability to be and act in his respective capacity of the Company.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(ii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is not and, at all times up to and including
consummation of the transactions contemplated by this Agreement, and after giving effect to application of the net proceeds of the Offering,
will not be, subject to registration as an &ldquo;investment company&rdquo; under the Investment Company Act of 1940, as amended, and
is not and will not be an entity &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo; within the meaning of such act.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(jj)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the knowledge of the Company, no relationship, direct
or indirect, exists between or among any of the Company or, to the knowledge of the Company, any Affiliate of the Company, on the one
hand, and any director, officer, shareholder, customer or supplier of the Company or, to the knowledge of the Company, any Affiliate
of the Company, on the other hand, which is required by the Securities Act, the Exchange Act or the Rules and Regulations to be described
in the Registration Statement or the Prospectus which is not so described as required. There are no outstanding loans, advances (except
normal advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company to or for the
benefit of any of the officers or directors of the Company or any of their respective family members. The Company has not, in violation
of Sarbanes-Oxley directly or indirectly extended or maintained credit, arranged for the extension of credit, or renewed an extension
of credit, in the form of a personal loan to or for any director or executive officer of the Company, except as disclosed in the Registration
Statement, the General Disclosure Package and the Prospectus.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(kk)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in material compliance with the rules
and regulations promulgated by the Nasdaq Stock Market LLC (to the extent applicable to the Company prior to the listing of the Common
Stock on the Nasdaq Capital Market LLC following the Closing) or any other governmental or self regulatory entity or agency having jurisdiction
over the Company, except for such violations which, singly or in the aggregate, would not have a Material Adverse Effect. Without limiting
the generality of the foregoing: (i) all members of the Company&rsquo;s board of directors who are required to be &ldquo;independent&rdquo;
(as that term is defined under applicable laws, rules and regulations), including, without limitation, all members of the audit committee
of the Company&rsquo;s board of directors, meet the qualifications of independence as set forth under the rules of The Nasdaq Stock Market
LLC and (ii) the audit committee of the Company&rsquo;s board of directors has at least one member who is an &ldquo;audit committee financial
expert&rdquo; (as that term is defined under applicable laws, rules and regulations).</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ll)&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(mm)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and each of its Subsidiaries owns or leases
all such properties (other than intellectual property, which is covered by Section 2(nn)) as are necessary to the conduct of its business
as presently operated as described in the Registration Statement, the General Disclosure Package and the Prospectus. The Company and
each of its Subsidiaries has good and marketable title in fee simple to all real property and good and marketable title to all personal
property owned by it, in each case free and clear of all Liens except such as are</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">described
in the Registration Statement, the General Disclosure Package and the Prospectus or such as do not (individually or in the aggregate)
materially affect the business or prospects of the Company or any of its Subsidiaries. Any real property and buildings held under lease
or sublease by the Company or any of its Subsidiaries are held by it under valid, subsisting and, to the Company&rsquo;s knowledge, enforceable
leases with such exceptions as are not material to, and do not materially interfere with, the use made and proposed to be made of such
property and buildings by the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries has received any notice
of any claim adverse to its ownership of any real or <FONT STYLE="letter-spacing: -0.05pt">personal</FONT> property or of any claim against
the continued possession of any real property, whether owned or held under lease or sublease by the Company or any of its Subsidiaries.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(nn)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and each of its Subsidiaries: (i) owns,
possesses, or has the adequate right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations,
service mark registrations, copyrights, licenses, formulae, customer lists, and know-how and other intellectual property (including trade
secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures, &ldquo;<B>Intellectual
Property</B>&rdquo;) necessary for the conduct of its businesses as being conducted and as described in the Registration Statement, the
General Disclosure and Prospectus and (ii) has no knowledge that the conduct of its business conflicts or will conflict with the rights
of others, and has not received any notice of any claim of conflict with, any right of others. Except as set forth in the Registration
Statement, the General Disclosure Package or the Prospectus, neither the Company nor any of its Subsidiaries has granted or assigned
to any other Person any right to sell any of the products or services of the Company or any of its Subsidiaries. To the Company&rsquo;s
knowledge, there is no infringement by third parties of any such Intellectual Property; there is no pending or, to the Company&rsquo;s
knowledge, threatened action, suit, proceeding or claim by others challenging the rights of the Company or any of its Subsidiaries in
or to any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim;
and there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others that the Company
or any of its Subsidiaries infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights
of others, and the Company is unaware of any other fact which would form a reasonable basis for any such claim. Except as set forth in
the Registration Statement, the General Disclosure Package and the Prospectus, neither the Company nor any of its Subsidiaries has received
any claim for royalties or other compensation from any Person, including any employee of the Company or any of its Subsidiaries who made
inventive contributions to the technology or products of the Company or any of its Subsidiaries that are pending or unsettled, and except
as set forth in the Registration Statement, the General Disclosure Package and the Prospectus neither the Company nor any of its Subsidiaries
has any obligation to pay material royalties to any Person on account of inventive contributions.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(oo)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The agreements and documents described in the Registration
Statement, the General Disclosure Package and the Prospectus conform to the descriptions thereof contained therein. Each agreement or
other instrument (however characterized or described) to which the Company or any of its Subsidiaries is a party or by which any of their
respective properties or <FONT STYLE="letter-spacing: -0.05pt">business are or may</FONT> be bound or affected and (i) that is referred
to in the Registration Statement, the General Disclosure Package or the Prospectus or attached as an exhibit thereto, or (ii) is material
to the businesses of the Company and its Subsidiaries, has been duly and validly</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">executed
by the Company or its Subsidiaries, as the case may be, is in full force and effect in all material respects and is enforceable against
the Company in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution provision may
be limited under the foreign, federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other
forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor
may be brought, and none of such agreements or instruments has been assigned by the Company or any of its Subsidiaries, and neither the
Company nor any of its Subsidiaries, nor, to the Company&rsquo;s knowledge, any other party is in breach or default thereunder and, to
the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute
a breach or default thereunder, in any such case, which would result in a Material Adverse Effect.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(pp)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The disclosures in the Registration Statement, the General
Disclosure Package and the Prospectus concerning the effects of foreign, federal, state and local regulation on the respective businesses
of the Company and each of its Subsidiaries as currently contemplated are correct in all material respects and do not omit to state a
material fact necessary to make the statements therein, in light of the circumstances in which they were made, not misleading.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(qq)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except for matters that would not, individually or in
the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and each of its Subsidiaries (i) has
made or filed all United States federal, state and local income and all Vietnam, Singapore, India and other foreign income and franchise
tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)
has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods
to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing
authority of any jurisdiction, and the officers of the Company know of no basis for any such claim. The provisions for taxes payable,
if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient for all accrued and unpaid
taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements. No deficiency
assessment with respect to a proposed adjustment of the federal, state, local or foreign taxes of the Company or any of its Subsidiaries
is pending or, to the Company&rsquo;s knowledge, threatened There is no tax lien, whether imposed by any federal, state, foreign or other
taxing authority, outstanding against the assets, properties or business of the Company or any of its Subsidiaries, other than liens
for taxes not yet delinquent, or being contested in good faith by appropriate proceedings and for which reserves in accordance with GAAP
have been established in the Company&rsquo;s books and records. The term &ldquo;taxes&rdquo; mean all federal, state, local, foreign
, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service,
service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties
or other taxes, fees, assessments, or charges in the nature of taxes, together with any interest and any penalties, additions to tax,
or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations, reports, statements, and
other documents required to be filed in respect to taxes.</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(rr)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No labor disturbance or dispute by or with the employees
of the Company or any of its Subsidiaries which, individually or in the aggregate, would reasonably be expected to have a Material Adverse
Effect, currently exists or, to the Company&rsquo;s knowledge, is threatened. The Company and each of its Subsidiaries is in compliance
in all material respects with the labor and employment laws and collective bargaining agreements and extension orders applicable to its
employees.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ss)&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[RESERVED.]</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(tt)&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[RESERVED.]</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(uu)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as disclosed in the Registration Statement, to
the knowledge of the Company the General Disclosure Package and the Prospectus, and would not be reasonably expected, individually or
in the aggregate, to have a Material Adverse Effect, the Company and each of its Subsidiaries has at all times operated its business
in material compliance with all Environmental Laws (as hereinafter defined), and no material expenditures are or will be required in
order to comply therewith. Neither the Company nor any of its Subsidiaries has received any notice or communication that relates to or
alleges any actual or potential violation or failure to comply with any Environmental Laws that would, individually or in the aggregate,
be reasonably expected to have a Material Adverse Effect. As used herein, the term &ldquo;<B>Environmental Laws</B>&rdquo; means all
applicable laws and regulations, including any licensing, permits or reporting requirements, and any action by a federal state or local
government entity pertaining to the protection of the environment, protection of public health, protection of worker <FONT STYLE="letter-spacing: -0.05pt">health
and safety, or the</FONT> handling of hazardous materials, including without limitation, the Clean Air Act, 42 U.S.C. &sect; 7401, et
seq., the Comprehensive Environmental Response, Compensation and Liability Act of 1980, 42 U.S.C. &sect; 9601, et seq., the Federal Water
Pollution Control Act, 33 U.S.C. &sect; 1321, et seq., the Hazardous Materials Transportation Act, 49 U.S.C. &sect; 1801, et seq., the
Resource Conservation and Recovery Act, 42 U.S.C. &sect; 690-1, et seq., and the Toxic Substances Control Act, 15 U.S.C. &sect; 2601,
et seq.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(vv)
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as would not result in a Material Adverse Effect,
neither the Company nor any of its Subsidiaries has failed to file with the applicable regulatory authorities any filing, declaration,
listing, registration, report or submission that is required to be so filed for the business operation of the Company and its Subsidiaries
as currently conducted. All such filings were in material compliance with applicable laws when filed and no deficiencies have been asserted
in writing by any applicable regulatory authority with respect to any such filings, declarations, listings, registrations, reports or
submissions. The Company and each of its Subsidiaries holds, and is in material compliance with, all franchises, grants, authorizations,
licenses, permits, easements, consents, certificates and orders (&ldquo;<B>Permits</B>&rdquo;) of any governmental or self-regulatory
agency, authority or body required for the conduct of the business of the Company and its Subsidiaries as currently conducted, and all
such Permits are in full force and effect, in each case except where the failure to hold, or comply with, any of them is not reasonably
likely to result in a Material Adverse Effect.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ww)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any Subsidiary of the Company
nor, to the knowledge of the Company, any other person associated with or acting on behalf of the Company or any Subsidiary including,
without limitation, any director, officer, agent or employee of the</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
or any Subsidiary, has, directly or indirectly, while acting on behalf of the Company or such Subsidiary: (i) used any corporate funds
for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (ii) made any unlawful payment
to <FONT STYLE="letter-spacing: -0.05pt">foreign or domestic government</FONT> officials or employees or to foreign or domestic political
parties <FONT STYLE="letter-spacing: -0.05pt">or campaigns from corporate</FONT> funds; (iii) violated any provision of the Foreign Corrupt
Practices Act of 1977, as amended; or (iv) made any other unlawful payment.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(xx)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any of its Subsidiaries or Affiliates
is subject to the <FONT STYLE="letter-spacing: -0.05pt">Bank Holding</FONT> Company Act of 1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;)
and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal Reserve</B>&rdquo;). Neither the Company
nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares
of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to
the BHCA and to <FONT STYLE="letter-spacing: -0.05pt">regulation by</FONT> the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(yy)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The operations of the Company and each of its Subsidiaries
are and have been conducted at all times in compliance in all material respects with applicable financial record keeping and reporting
requirements and money laundering statutes of the United States, <FONT STYLE="letter-spacing: -0.05pt">Vietnam, Singapore and India</FONT>
and, to the Company&rsquo;s knowledge, all other jurisdictions to which the Company is subject, the rules and regulations thereunder
and any related or similar rules, regulations or guidelines, issued, administered or enforced by any applicable governmental agency (collectively,
the &ldquo;<B>Money Laundering Laws</B>&rdquo;) and no action, suit or proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to
the best knowledge of the Company, threatened.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(zz)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither the Company nor any of its Subsidiaries nor
to the knowledge of the Company, any director, officer, agent, employee or Affiliate of the Company or any of its Subsidiaries is currently
subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<B>OFAC</B>&rdquo;),
the United Nations Security Council, the European Union, her Majesty&rsquo;s Treasury (UK HMT), the Swiss Secretariat of Economic Affairs,
the Monetary Authority of Singapore or other relevant authorities (collectively, &ldquo;<B>Sanctions</B>&rdquo;) nor located, organized
or resident in a country or territory that is the subject of Sanctions. The Company will not directly or indirectly use the proceeds
of the Offering, or lend, contribute or otherwise make available such proceeds to any joint venture partner or other person or entity,
for the purpose of funding or financing the activities or business of or with any Person or in any country or territory that. At the
time of such funding or facilitation is the subject of to any Sanctions, or in any other manner that will result in a violation of Sanctions
by any Person (including any Person participating in the Offering). For the past five years, neither the Company nor any of its Subsidiaries
has knowingly engaged in, is not now knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in
any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(aaa)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">Except as set forth in the
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Statement, the General Disclosure Package
and the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by this Agreement. To the Company&rsquo;s knowledge, there are no other arrangements, agreements or understandings of the Company or,
to the Company&rsquo;s knowledge, any of its Affiliates that may affect the Underwriters&rsquo; compensation, as determined by FINRA.
The Company has not made any direct or indirect payments (in cash, securities or otherwise) to (i) any person, as a finder&rsquo;s fee,
investing fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who
provided capital to the Company, (ii) any FINRA <FONT STYLE="letter-spacing: -0.05pt">member, or</FONT> (iii) any person or entity that
has any direct or indirect affiliation or association with any FINRA member participating in the Offering within the 12-month period
prior to the date on which the Registration Statement was filed with the Commission (the &ldquo;<B>Filing Date</B>&rdquo;) or thereafter.
To the Company&rsquo;s knowledge, no (i) officer or director of the Company or its Subsidiaries, (ii) owner of 5% or more of the Company&rsquo;s
unregistered securities or that of its Subsidiaries or (iii) owner of any amount of the Company&rsquo;s unregistered securities acquired
within the 180-day period prior to the Filing Date, has any direct or indirect affiliation or association with any FINRA member participating
in the Offering. The Company will advise the Underwriters and their respective counsel if it becomes aware that any officer, director
or stockholder of the Company or its Subsidiaries is or becomes an affiliate or associated person of a FINRA member participating in
the Offering.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(bbb)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and each of its Subsidiaries maintains insurance
in such amounts and covering such risks as the Company reasonably considers adequate for the conduct of their respective businesses and
the value of their respective properties and as is customary for companies engaged in similar businesses in similar industries, all of
which insurance is in full force and effect, except where the failure to maintain such insurance could not reasonably be expected to
have Material Adverse Effect. The Company reasonably believes that it and each of its Subsidiaries will be able to renew its existing
insurance as and when such coverage expires or will be able to obtain replacement insurance adequate for the conduct of its respective
business and the value of its respective properties at a cost that would not have a Material Adverse Effect.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ccc)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As used in this Agreement, references to matters being
&ldquo;<B>material</B>&rdquo; with respect to the Company or any of its Subsidiaries shall mean a material event, change, condition,
status <FONT STYLE="letter-spacing: -0.05pt">or effect related to the condition</FONT> (financial or otherwise), properties, assets (including
intangible assets), liabilities, business, prospects, operations or results of operations of the Company and such Subsidiaries either
individually or taken as a whole, as the context requires.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ddd)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As used in this Agreement, the term &ldquo;<B>knowledge
of the Company</B>&rdquo; (or similar language) shall mean the knowledge of the &ldquo;named executive officers&rdquo; of the Company
who are named in the Prospectus, with the assumption that such executive officers shall have made reasonable and diligent inquiry of
the matters presented (with reference to what is customary and prudent for the applicable individuals in connection with the discharge
by the applicable individuals of their duties as executive officers of the Company).</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(eee)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any certificate signed by or on behalf of the Company
and delivered to the Underwriters or to Loeb &amp; Loeb LLP (&ldquo;<B>Underwriters&rsquo; Counsel</B>&rdquo;) shall be deemed to be
a representation and warranty by the Company to each Underwriter listed on <U>Schedule A</U> hereto as to the matters covered thereby.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Offering</U>. Upon authorization of the release of
the Securities by the Representative, the Underwriters propose to offer the Securities for sale to the public upon the terms and conditions
set forth in the Prospectus.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">4.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Covenants of the Company</U>. The Company acknowledges,
covenants and agrees with the Representative that:</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registration Statement and any amendments thereto
have been declared effective, and if Rule 430A is used or the filing of the Prospectus is otherwise required under Rule 424(b), the Company
will file the Prospectus (properly completed if Rule 430A has been used) pursuant to Rule 424(b) within the prescribed time period and
will provide evidence satisfactory to the Representative of such timely filing. The Company will file with the Commission all Issuer
Free Writing Prospectuses in the time and manner required under Rules 433(d) or 163(b)(2), as the case may be.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period beginning on the date hereof and ending
on the later of the Closing Date or such date as, in the opinion of Underwriters&rsquo; Counsel, the Prospectus is no longer required
by law to be delivered (or in lieu thereof the notice referred to in Rule 173(a) under the Securities Act is no longer required to be
provided), in connection with sales by an underwriter or dealer (the &ldquo;<B>Prospectus Delivery Period</B>&rdquo;), prior to amending
or supplementing the Registration Statement or the Prospectus, the Company shall furnish to the Representatives for review a copy of
each such proposed amendment or supplement, and the Company shall not file any such proposed amendment or supplement to which the Representatives
reasonably object within 36 hours of delivery thereof to the Representatives and Underwriters&rsquo; Counsel.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After the date of this Agreement, the Company shall
promptly advise the Representative in writing (i) of the receipt of any comments of, or requests for additional or supplemental information
from, the Commission, (ii) of the time and date of any filing of any post-effective amendment to the Registration Statement or any amendment
or supplement to any prospectus, the General Disclosure Package or the Prospectus, (iii) of the time and date that any post-effective
amendment to the Registration Statement becomes effective, and (iv) of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or any post-effective amendment thereto or of any order preventing or suspending its use
or the use of any prospectus, the General Disclosure Package, the Prospectus or any Issuer- Represented Free Writing Prospectus, or of
any proceedings to remove, suspend or terminate from listing the Common Stock from any securities exchange upon which they are listed
for trading, or of the threatening or initiation of any proceedings for any of such purposes. If the Commission shall enter any such
stop order at any time, the Company will use its reasonable efforts to obtain the lifting of such order at the earliest possible moment.
Additionally, the Company agrees that it shall comply with the provisions of Rules 424(b), 430A and 430B, as applicable, under the Securities
Act and will use its commercially reasonable efforts to confirm</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
any filings made by the Company under Rule 424(b) or Rule 433 were received in a timely manner by the Commission (without reliance on
Rule 424(b)(8) or Rule 164(b)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(d)&nbsp;
</FONT>(i) During the Prospectus Delivery Period, the Company will comply in all material respects with all requirements imposed upon
it by the Securities Act, as now and hereafter amended, and by the Rules and Regulations, as from time to time in force, and by the Exchange
Act so far as necessary to permit the continuance of sales of or dealings in the Securities as contemplated by the provisions hereof,
the General Disclosure Package, the Registration Statement and the Prospectus. If during such period any event occurs as a result of
which the Prospectus (or if the Prospectus is not yet available to prospective purchasers, the General Disclosure Package ) would include
an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the
circumstances under which such statements were made, not misleading, or if during such period it is necessary or appropriate in the opinion
of the Company or its counsel or the Representative or Underwriters&rsquo; Counsel to amend the Registration Statement or supplement
the Prospectus (or if the Prospectus is not yet available to prospective purchasers, the General Disclosure Package) to comply with the
Securities Act or to file under the Exchange Act any document which would be deemed to be incorporated by reference in the Prospectus
in order to comply with the Securities Act or the Exchange Act, the Company will promptly notify the Representative and will amend the
Registration Statement or supplement the Prospectus (or if the Prospectus is not yet available to prospective purchasers, the General
Disclosure Package) or file such document (at the expense of the Company) so as to correct such statement or omission or effect such
compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
to comply with the Securities Act or to file under the Exchange Act any document which would be deemed to be incorporated by reference
in the Prospectus in order to comply with the Securities Act or the Exchange Act, the Company will promptly notify the Representative
and will amend the Registration Statement or supplement the Prospectus (or if the Prospectus is not yet available to prospective purchasers,
the General Disclosure Package) or file such document (at the expense of the Company) so as to correct such statement or omission or
effect such compliance.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If at any time following issuance of an Issuer-Represented
Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer- Represented Free Writing Prospectus
conflicted or would conflict with the information contained in the Registration Statement, the Statutory Prospectus or the Prospectus
or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances prevailing at that subsequent time, not misleading, the Company has
promptly notified or promptly will notify the Representative and has promptly amended or will promptly amend or supplement, at its own
expense, such Issuer-Represented Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(e)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will promptly deliver to the Underwriters
and Underwriters&rsquo; Counsel a signed copy of the Registration Statement, as initially filed and all amendments thereto, including
all consents and exhibits filed therewith, and will maintain in the Company&rsquo;s files manually signed copies of such documents for
at least five (5) years after the date of filing thereof. The Company will promptly deliver to each of the Underwriters such number of
copies of any Preliminary Prospectus, the Prospectus, the Registration Statement, and all amendments of and supplements to such documents,
if any, and all documents which are exhibits to the Registration Statement and Prospectus or any amendment thereof or supplement thereto,
as the <FONT STYLE="letter-spacing: -0.05pt">Underwriters may</FONT> reasonably request. Prior to 10:00 a.m., New York time, on the Business
Day next succeeding the date of this Agreement and from time to time thereafter, the Company will furnish the Underwriters with copies
of the Prospectus in New York City in such quantities as the Underwriters may reasonably request.</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(f)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company consents to the use and delivery of the
Preliminary Prospectus by the Underwriters in accordance with Rule 430 and Section 5(b) of the Securities Act.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(g)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company elects to rely on Rule 462(b) under the
Securities Act, the Company shall both file a Rule 462(b) Registration Statement with the Commission in compliance with Rule 462(b) and
pay the applicable fees in accordance with Rule 111 of the Securities Act by the earlier of: (i) 10:00 p.m., New York City time, on the
date of this <FONT STYLE="letter-spacing: -0.05pt">Agreement, and (ii)</FONT> the time that confirmations are given or sent, as specified
by Rule 462(b)(2).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(h)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will use its commercially reasonable efforts,
in cooperation with the Representative, at or prior to the time of effectiveness of the Registration Statement, to qualify the Securities
for offering and sale under the securities laws relating to the offering or sale of the Securities of such jurisdictions, domestic or
foreign, as the Representative may reasonably designate and to maintain such qualification in effect for so long as required for the
distribution thereof, except that in no event shall the Company be obligated in connection therewith to qualify as a foreign corporation
or other entity or as a dealer in securities in any such jurisdiction, to execute a general consent to service of process in any such
jurisdiction, or to subject itself to taxation in any such jurisdiction if it is otherwise not so subject.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(i)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the 180 day period following the date of this
Agreement (the &ldquo;<B>Company Lock-up Perio</B>d&rdquo;), the Company may not, without the prior written consent of the Representative,
(i) offer, sell, issue, agree or contract to sell or issue or grant any option for the sale of any securities of the Company, except
for (A) the issuance of securities to employees, directors and service providers or issuances under the Society Pass Incorporated 2021
Equity Incentive Plan (B) the issuance of shares of Common Stock upon the exercise or conversion of securities that are issued and outstanding
on the date of this Agreement and are described in the <FONT STYLE="letter-spacing: -0.05pt">Registration Statement</FONT> and the Prospectus,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to
decrease the exercise price or conversion price of such securities (other than in connection with stock splits, adjustments or combinations
as set forth in such securities) or to extend the term of such securities; and (C) the issuance of securities issued pursuant to acquisitions
or strategic transactions; provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith within 180 days
following the Closing Date, but shall not include a transaction in which the Company is issuing securities primarily for the purpose
of raising capital or to an entity whose primary business is investing in securities; or (ii) file any registration statement relating
to the offer or sale of any of the Company&rsquo;s securities. Notwithstanding the forgoing, at any time after the 45th day after the
Closing Date, the Company may file a registration statement with the Commission, to register for resale, up to 2.5 million shares (the
&ldquo;Resale Shares&rdquo;) of Common Stock held by certain shareholders of the Company as of the Closing Date of the Offering; provided
however, the Resale Shares shall, in no event, include shares of Common Stock held by any of the Company&rsquo;s directors, officers
and affiliates.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(j)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule II</U> hereto contains a complete and accurate
list of the Company&rsquo;s executive officers, directors and holders of 5% or more of the Company&rsquo;s Common Stock (collectively,
the &ldquo;<B>Lock-Up Parties</B>&rdquo;). The Company has caused each of the Lock-Up Parties</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to deliver
to the Representative an executed Lock-Up Agreement, in the form attached hereto as <U>Annex I</U> <B>(</B>the &ldquo;<B>Lock-Up Agreement</B>&rdquo;),
prior to the execution of this Agreement</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(k)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Representative, in its sole discretion, agrees
to release or waive the restrictions set forth in a Lock-Up Agreement described in Section 4(j) hereof for an officer or director of
the Company and provide the Company with notice of the impending release or waiver at least three Business Days before the effective
date of the release or waiver, the <FONT STYLE="letter-spacing: -0.05pt">Company</FONT> agrees to announce the impending release or waiver
by (i) a press release substantially in the form of <U>Annex V</U> hereto through a major news service or (ii) any other method that
satisfies the obligations described in FINRA Rule 5131(d)(2) at least two Business Days before the effective date of the release or waiver.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(l)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, at its expense, shall register with and,
for a period of three (3) years after the Closing Date, keep current, its registration in the Standard &amp; Poor&rsquo;s Corporation
Records Services (including annual report information).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(m)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For a period of at least one (1) year from the Effective
Date, the Company shall retain a nationally recognized PCAOB registered independent public accounting firm <FONT STYLE="letter-spacing: -0.05pt">reasonably
acceptable</FONT> to the Representative. The Representative acknowledges that the Auditor is acceptable to the Representative.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(n)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period of one (1) year from the Effective
Date, the Company will make available to the Representative copies of all reports or other communications (financial or other) furnished
to security holders or from time to time published or publicly disseminated by the Company, and will deliver to the Representative: (i)
as soon as practicable after they are available, copies of any reports, financial statements and proxy or information statements furnished
to or filed with the Commission or any national securities exchange on which any class of securities of the Company is listed; and (ii)
such additional information concerning the business and financial condition of the Company as the Representative may from time to time
reasonably request in writing pursuant to a specific regulatory or liability issue or; provided, that any such item which is available
on the EDGAR system (or successor thereto) need not be furnished in physical form.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(o)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will not issue press releases or engage
in any other publicity without the Representative&rsquo;s prior written consent, for a period ending at 5:00 p.m. Eastern time on the
first Business Day following the fortieth (40th) day following the Closing Date, other than normal and customary releases issued in the
ordinary course of the Company&rsquo;s business, or as required by law.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(p)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company hereby grants the Representative the right
of first refusal (&ldquo;Right of First Refusal&rdquo;) for a period of twelve (12) months after the closing of this Offering to act
as lead left book-runner and lead left manager and/or lead left placement agent with at least 75% of the economics for a two-handed deal
and 50% of the economics for a three-handed deal for any and all future private and public equity, convertible or debt offerings (each,
a &ldquo;Subject Transaction&rdquo;) undertaken by the Company or any successor or subsidiary of the Company. The Company shall notify
the Representative of its intention to pursue a Subject Transaction, including the material terms thereof, by providing written notice
thereof by registered mail or</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">overnight
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">courier service addressed to the Representative. If
the Representative fails to exercise its Right of First Refusal with respect to any Subject Transaction within five (5) Business Days
after the mailing of such written notice, then the Representative shall have no further claim or right with respect to the Subject Transaction.
The Representative may elect, in its sole and absolute discretion, not to exercise its Right of First Refusal with respect to any Subject
Transaction; provided that any such election by the Representative shall not adversely affect the Representative&rsquo;s Right of First
Refusal with respect to any other Subject Transaction during the tweleve (12) month period agreed to above.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(q)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will apply the net proceeds from the sale
of the Securities as set forth under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(r)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will use its reasonable best efforts to
effect and maintain the listing of the Common Stock on the Nasdaq Stock Market, the NYSE, or the NYSE American for at least two (2) years
after the Closing Date.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(s)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, during the Prospectus Delivery Period,
will file all documents required to be filed with the Commission pursuant to the Securities Act, the Exchange Act and the Rules and Regulations
within the time periods required thereby.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(t)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will use its commercially reasonable efforts
to do and perform all things required to be done or performed under this Agreement by the Company prior to the Closing Date, and to satisfy
all conditions precedent to the delivery of the Securities.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(u)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will not take, and will use its commercially
reasonable efforts to cause its Affiliates not to take, directly or indirectly, any action which constitutes or is designed to cause
or result in, or which could reasonably be expected to constitute, cause or result in, the stabilization or manipulation of the price
of any security to facilitate the sale or resale of the Securities.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(v)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company shall cause to be prepared and delivered
to the Representative, at its expense, within two (2) Business Days from the effective date of this Agreement, an Electronic Prospectus
to be used by the Underwriters in connection with the Offering. As used herein, the term &ldquo;Electronic Prospectus&rdquo; means a
form of prospectus, and any amendment or supplement thereto, that meets each of the following conditions: (i) it shall be encoded in
an electronic format, satisfactory to the Representative, that may be transmitted electronically by the other Underwriters to offerees
and purchasers of the Securities for at least the period during which a Prospectus relating to the Securities is required to be delivered
under the Securities Act; (ii) it shall disclose the same information as the paper prospectus and prospectus filed pursuant to EDGAR,
except to the extent that graphic and image material cannot be disseminated electronically, in which case such graphic and image material
shall be replaced in the electronic prospectus with a fair and accurate narrative description or tabular representation of such material,
as appropriate; and (iii) it shall be in or convertible into a paper format or an electronic format, satisfactory to the Representative,
that will allow recipients thereof to store and have continuously ready access to the prospectus at any future time, without charge to
such recipients (other than any fee charged for subscription to the Internet as a whole and for on-line time).</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(w)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company represents and agrees that, unless it obtains
the prior written consent of the Representative, and the Representative represents and agrees that, unless it obtains the prior written
consent of the Company, it has not made and will not make any offer relating to the Securities that would constitute an &ldquo;issuer
free writing prospectus,&rdquo; as defined in Rule 433 under the Securities Act, or that would otherwise constitute a &ldquo;free writing
prospectus,&rdquo; as defined in Rule 405 under the Securities Act, required to be filed with the Commission; provided that the prior
written consent of the parties hereto shall be deemed to have been given in respect of the free writing prospectuses included in <U>Schedule
II</U>. Any such free writing prospectus consented to by the Company and the Representative is hereinafter referred to as a &ldquo;Permitted
Free Writing Prospectus.&rdquo; Each of the Company and the Representative represents that it has treated or agrees that it will treat
each Permitted Free Writing Prospectus as an &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433, and has complied and
will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely Commission filing
where required, legending and record keeping.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">5.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payment of Expenses</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether or not the transactions contemplated by this
Agreement, the Registration Statement and the Prospectus are consummated or this Agreement is terminated, the Company hereby agrees to
pay all reasonable and documented costs and expenses incident to the performance of its obligations hereunder including the following:</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(i)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all filing fees and communication expenses related to
the registration of the Securities to be sold in the Offering including all expenses in connection with the preparation, printing, formatting
for EDGAR and filing of the Registration Statement, any Preliminary Prospectus and the Prospectus and any and all amendments and supplements
thereto and the mailing and delivering of copies thereof to the Underwriters and dealers;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(ii)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all fees and expenses in connection with filings with
FINRA;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(iii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all fees, disbursements and expenses of the Company&rsquo;s
counsel and accountants in connection with the registration of the Securities under the Securities Act and the Offering;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(iv)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all fees and expenses in connection with listing the
Common Stock on the Nasdaq Capital Market;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(v)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs of all mailing and printing of the underwriting
documents (including this Agreement, any blue sky surveys and, if appropriate, any Agreement Among <FONT STYLE="letter-spacing: -0.05pt">Underwriters,
Selected</FONT> Dealers&rsquo; Agreement, Underwriters&rsquo; Questionnaire and Power of Attorney);</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(vi)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">all reasonable travel</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses of the Company&rsquo;s officers and employees and
any other expenses incurred in connection with attending or hosting meetings with prospective purchasers of the Securities;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(vii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any stock transfer taxes payable upon the transfer of
securities by the Company to the Underwriters and any other taxes incurred by the Company in connection with this Agreement or the Offering;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(viii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">the costs associated with</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">book building, prospectus tracking and compliance software
and the cost of preparing certificates representing the Securities;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(ix)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the cost and charges of any transfer agent or registrar
for the Common Stock;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(x)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any reasonable cost and expenses in conducting background
checks of the Company&rsquo;s officers and directors by a background search firm acceptable to the Representative;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(xi)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fees of Underwriters&rsquo; Counsel;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(xii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the cost of preparing, printing and delivering certificates
representing each of the Securities; and</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(xiii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all other costs, fees and expenses incident to the performance
of the Company obligations hereunder which are not otherwise specifically provided for in this Section 5.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and the Representative acknowledge that the Company has previously paid to the Representative advances in an amount of $15,000
(the &ldquo;<B>Advance&rdquo;</B>) against the Representative&rsquo;s out-of-pocket expenses. Any portion of the Advance not used shall
be returned back to the Company to the extent not incurred. The Representative&rsquo;s total out-of-pocket accountable expenses (including
reasonable and documented legal fees and expenses) in connection with the Offering shall not exceed $230,000 (inclusive of the Advance
previously paid to the Representative). In the event the Offering is terminated prior to the Closing Date, the Representative&rsquo;s
total out-of-pocket accountable expenses (including reasonable and documented legal fees and expenses) in connection with the Offering
shall not exceed $125,000, inclusive of the Advance and the Representative shall return any portion of the Advance not used to pay its
accountable out-of-pocket expenses actually incurred.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">6.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conditions of Underwriters&rsquo; Obligations</U>.
The obligations of the Underwriters to purchase and pay for the Firm Shares or the Option Shares, as the case may be, as provided herein
shall be subject to: (i) the accuracy of the representations and warranties of the Company herein contained, as of the date hereof and
as of the Closing Date, (ii) the absence from any certificates, opinions, written statements or letters furnished to the Representative
or to Underwriters&rsquo; Counsel pursuant to this Section 6 of any misstatement or omission, (iii) the performance by the Company of
its obligations hereunder, and (iv) each of the following additional conditions. For purposes of this Section 6, the terms &ldquo;Closing
Date&rdquo; and &ldquo;Closing&rdquo; shall refer to the Closing Date for the Firm Shares or the Option Shares, as the case may be, and
each of the foregoing and following conditions must be satisfied as of each Closing.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registration Statement shall have become effective
and all necessary regulatory or listing approvals shall have been received not later than 5:30 p.m., New York time, on the date of this
Agreement, or at such later time and date as shall have been consented</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
in writing by the Representative. If the Company shall have elected to rely upon Rule 430A under the Securities Act, the Prospectus shall
have been filed with the Commission in a timely <FONT STYLE="letter-spacing: -0.05pt">fashion in accordance</FONT> with the terms hereof
and a form of the Prospectus containing information relating to the description of the Securities and the method of distribution and
similar matters shall have been filed with the Commission pursuant to Rule 424(b) within the applicable time period; and, at or prior
to the Closing Date or the actual time of the Closing, no stop order suspending the effectiveness of the Registration Statement or any
part thereof, or any amendment thereof, nor suspending or preventing the use of the General Disclosure Package, the Prospectus or any
Issuer Free Writing Prospectus shall have been issued; no proceedings for the issuance of such an order shall have been initiated or
threatened; any request of the Commission for additional information (to be included in the Registration Statement, the General Disclosure
Package, the Prospectus, any Issuer Free Writing Prospectus or otherwise) shall have been complied with to the Representative&rsquo;s
satisfaction; and FINRA shall have raised no objection to the fairness and reasonableness of the underwriting terms and arrangements.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Representative shall not have reasonably determined,
and advised the Company, that the Registration Statement, the General Disclosure Package or the Prospectus, or any amendment thereof
or supplement thereto, or any Issuer Free Writing Prospectus, contains an untrue statement of fact which, in the Representative&rsquo;s
reasonable opinion, is material, or omits to state a fact which, in the Representative&rsquo;s reasonable opinion, is material and is
required to be stated therein or necessary to make the statements therein not misleading; provided, however, that if in the Representative&rsquo;s
opinion such deficiency is curable Representative shall have given the Company reasonable notice of such deficiency and a reasonable
chance to cure such deficiency.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Representative shall have received the written opinions
of (i) Carmel Milazzo &amp; Feil LLP, the U.S. securities counsel for the Company, dated as of the Closing Date and addressed to the
Representative substantially in the form attached hereto as <U>Annex II</U>, (ii) <FONT STYLE="letter-spacing: -0.05pt">The Crone Law
Law</FONT> Firm Group P.C , Nevada counsel for the Company dated as of the Closing Date and addressed to the Representative substantially
in the form attached hereto as <U>Annex III,</U> and (iii) BFSC &ndash; International Finance and Business Law Firm, Vietnamese counsel
for the Company dated as of the Closing Date and addressed to the Representative substantially in the form attached hereto as <U>Annex
IV.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><FONT STYLE="color: #010000; letter-spacing: -0.05pt">(d)&nbsp;
</FONT>The Representative shall have received a certificate of the Chief Executive Officer and Chief Financial Officer of the Company,
dated as of each Closing Date, to the effect that: (i) the condition set forth in subsection (a) of this Section 6 has been satisfied,
(ii) as of the date hereof and as of the applicable Closing Date, the representations and warranties of the Company set forth in Sectiond
2 hereof are accurate, (iii) as of the applicable Closing Date, all agreements, conditions and obligations of the Company to be performed
or complied with hereunder on or prior thereto have been duly performed or complied with, (iv) the Company has not sustained any material
loss or interference with their respective businesses, whether or not covered by insurance, or from any labor dispute or any legal or
governmental proceeding, (v) no stop order suspending the effectiveness of the Registration Statement or any post- effective amendment
thereof has been issued and no proceedings therefor have been initiated or threatened by the Commission, (vi) there are no pro forma
or as adjusted financial statements that are required to be included or incorporated by reference in the Registration Statement and</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Prospectus pursuant to the Rules and Regulations which are not so included or incorporated by reference, and (vii) subsequent to the
respective dates as of which information is given in the Registration Statement and the Prospectus there has not been any Material Adverse
Change or any development involving a prospective Material Adverse Change, whether or not arising from transactions in the ordinary course
of business.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(e)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the date of this Agreement and on each Closing Date,
the Representative shall have received a &ldquo;cold comfort&rdquo; letter from the Auditor as of the date of delivery and addressed
to the Representative and in form and substance satisfactory to the Representative and Underwriters&rsquo; Counsel, confirming that they
are independent certified public accountants with respect to the Company within the meaning of the Securities Act and the Rules and <FONT STYLE="letter-spacing: -0.05pt">Regulations,
and stating,</FONT> as of the date of delivery (or, with respect to matters involving changes or developments since the respective dates
as of which specified financial information is given in the Prospectus, as of a date not more than five (5) days prior to the date of
such letter), the <FONT STYLE="letter-spacing: -0.05pt">conclusions</FONT> and findings of such firm with respect to the financial information
and other matters relating to the Registration Statement and the Prospectus covered by such letter.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(f)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to the execution and delivery of this Agreement
and prior to the Closing Date, there shall not have been any change in the capital stock or long-term debt of the Company or any change
or development involving a change, whether or not arising from transactions in the ordinary course of business, in the business, condition
(financial or otherwise), results of operations, shareholders&rsquo; equity, properties or prospects of the Company including but not
limited to the occurrence of any fire, flood, storm, explosion, accident, act of war or terrorism or other calamity, the effect of which,
in any such case described above, is, in the sole judgment of the Representative, so material and adverse as to make it impracticable
or inadvisable to proceed with the Offering on the terms and in the manner contemplated in the Prospectus (exclusive of any supplement).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(g)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the execution and delivery of this Agreement,
the Representative shall have received a lock-up agreement from each Lock-Up Party, duly executed by the applicable Lock-Up Party, in
each case substantially in the form attached hereto as <U>Annex I</U>.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(h)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Common Stock is registered under the Exchange Act
and, as of the Closing Date, the Common Stock shall be listed and admitted and authorized for trading on the Nasdaq Capital Market and
satisfactory evidence of such action shall have been provided to the Representative. The Company shall have taken no action designed
to, or likely to have the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending
from trading the Common Stock from the Nasdaq Capital Market, nor has the Company received any information suggesting that the Commission
or the Nasdaq Capital Market is contemplating terminating such registration of listing. The Shares, the Representative&rsquo;s Warrants
and the shares of Common Stock underlying the Representative&rsquo;s Warrants shall be DTC eligible.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(i)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA shall have confirmed that it has not raised any
objection with respect to the fairness and reasonableness of the underwriting terms and arrangements.</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(j)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No action shall have been taken and no statute, rule,
regulation or order shall <FONT STYLE="letter-spacing: -0.05pt">have been enacted,</FONT> adopted or issued by any federal, state or
foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and
no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the
issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations
of the Company.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(k)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">The Company</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
have furnished the Representative with a Certificate of Good Standing for the Company certified by the Secretary of State of the State
of Nevada and a Certificate of Good Standing (or equivalent document) for each of its Subsidiaries certified by the respective appropriate
governmental authority in the jurisdiction of its incorporation or formation if such governmental authorities issue such certificates.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(l)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company shall have furnished the Representative
and Underwriters&rsquo; Counsel with such other certificates, opinions or other documents as they may have reasonably requested.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(m)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Closing Date, there shall have been issued to
the Representative, a Representative&rsquo;s Warrant in the form attached hereto as <U>Annex VI.</U></FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this Section 6 shall not have been fulfilled when and as required by this Agreement, or if any of
the certificates, opinions, written statements or letters furnished to the Representative or to Underwriters&rsquo; Counsel pursuant
to this Section 6 shall not be reasonably satisfactory in form and substance to the Representative and to Underwriters&rsquo; Counsel,
all obligations of the Underwriters hereunder may be cancelled by the Representative at, or at any time prior to, the consummation of
the Closing. Notice of such cancellation shall be given to the Company in writing or by telephone. Any such telephone notice shall be
confirmed promptly thereafter in writing.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">7.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnification</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agrees to indemnify and hold harmless each
Underwriter, its officers, directors and employees, and each Person, if any, who controls such Underwriter within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act, against any losses, liabilities, claims, damages and expenses whatsoever
as incurred (including but not limited to reasonable attorneys&rsquo; fees and any and all expenses whatsoever incurred in investigating,
preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement
of any claim or litigation), joint or several, to which they or any of them may become subject under the Securities Act, the Exchange
Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent of the Company),
insofar as such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon (i) an
untrue statement or alleged untrue statement of a material fact contained in (A) the Registration Statement, including the information
deemed to be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and
430B of the Rules and Regulations, the General Disclosure Package, the Prospectus, or any amendment or supplement thereto (including
any documents filed under the Exchange Act and deemed to be</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">incorporated
by</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reference into the Prospectus), (B) any Issuer Free
Writing Prospectus or in any other materials or information provided to investors by, or with the approval of, the Company in connection
with the marketing of the offering of the Securities, including any road show or investor presentations made to investors by the Company
(whether in person or electronically) <FONT STYLE="letter-spacing: -0.05pt">(collectively</FONT> &ldquo;<B>Marketing Materials</B>&rdquo;)
or (C) any filings or reports filed by the Company under the Exchange Act or arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse
such indemnified party for any legal or other expenses <FONT STYLE="letter-spacing: -0.05pt">reasonably</FONT> incurred by it in connection
with investigating or defending against such loss, claim, damage, liability or action; or (ii) in whole or in part upon any inaccuracy
in the representations and warranties of the Company contained herein; or (iii) in whole or in part upon any failure of the Company to
perform its obligations hereunder or under law; provided, however, that the Company shall not be liable in any such case to the extent
that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement
or omission or alleged omission made in the Registration Statement, any Preliminary Prospectus, the General Disclosure Package, the Prospectus,
or any such amendment or supplement, any Issuer Free Writing Prospectus or any other Marketing Materials, in reliance upon and in conformity
with the Underwriters&rsquo; Information. With respect to any untrue statement or omission or alleged untrue statement or omission made
in the Preliminary Prospectus, the indemnity agreement contained in this Section 7(a) shall not inure to the benefit of an Underwriter
to the extent that any loss, liability, claim, damage or expense of such Underwriter results from the fact that a copy of the Prospectus
was not given or sent to the Person asserting any such loss, liability, claim or damage at or prior to the written confirmation of sale
of the Securities to such Person as required by the Securities Act and the rules and regulations thereunder, and if the untrue statement
or omission has been corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of non-compliance by the
Company with its obligations under this Agreement.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each Underwriter, severally and not jointly, shall indemnify
and hold harmless the Company, each of the directors of the Company, each of the officers of the Company who shall have signed the Registration
Statement, and each other Person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act, against any losses, liabilities, claims, damages and expenses whatsoever as incurred (including but not limited
to attorneys&rsquo; fees and any and all expenses whatsoever incurred in investigating, preparing or defending against any litigation,
commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint or several,
to which they or any of them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such losses, liabilities,
claims, damages or expenses (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement, as originally filed or any amendment thereof, or any related Preliminary
Prospectus or the Prospectus, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in
each case to the extent, but only to the extent, that any such loss, liability, claim, damage or expense arises out of or is based upon
any such</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">untrue
statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with the Underwriters&rsquo;
Information; provided, however, that in no case shall any Underwriter be liable or responsible for any amount in excess of the aggregate
underwriting discount applicable to the Securities to be purchased by such Underwriter hereunder. The parties agree that such information
provided by or on behalf of any Underwriter through the Representative consists solely of the material referred to in the last sentence
of Section 2(b) hereof.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly after receipt by an indemnified party under
subsection (a) or (b) above of notice of any claims or the commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against the indemnifying party under such subsection, notify each party against whom indemnification is to be sought
in writing of the claim or the commencement thereof (but the failure so to notify an indemnifying party shall not relieve the indemnifying
party from any liability which it may have under this Section 7 to the extent that it is not materially prejudiced as a result thereof
and in any event shall not relieve it from any liability that such indemnifying party may have otherwise than on account of the indemnity
agreement hereunder). In case any such claim or action is brought against any indemnified party, and it notifies an indemnifying party
of the commencement thereof, the indemnifying party will be entitled to participate, at its own expense in the defense of such action,
and to the extent it may elect by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from
such indemnified party, to assume the defense thereof with counsel satisfactory to such indemnified party; provided however, that counsel
to the indemnifying party shall not (except with the written consent of the indemnified party) also be counsel to the indemnified party.
Notwithstanding the foregoing, the indemnified party or parties shall have the right to employ its or their own counsel in any such case,
but the fees and expenses of such counsel shall be at the expense of such indemnified party or parties unless (i) the employment of such
counsel shall have been authorized in writing by one of the indemnifying parties in connection with the defense of such action, (ii)
the indemnifying parties shall not have employed counsel to have charge of the defense of such action within a reasonable time after
notice of commencement of the action, (iii) the indemnifying party does not diligently defend the action after assumption of the defense,
or (iv) such indemnified party or parties shall have reasonably concluded, based upon the written advice of its counsel, that a conflict
may arise between the positions of the indemnifying party and the indemnified party, or any of them, in conducting the defense of any
such action or that there may be legal defenses available to it or them which are different from or additional to those available to
one or all of the indemnifying parties (in which case the indemnifying parties shall not have the right to direct the defense of such
action on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the indemnifying
parties and shall be paid as incurred. No indemnifying party shall, without the prior written consent of the indemnified parties (which
consent shall not be unreasonably withheld, conditioned or delayed), effect any settlement or compromise of, or consent to the entry
of judgment with respect to, any pending or threatened claim, investigation, action or proceeding in respect of which indemnity or contribution
may be or could have been sought by an indemnified party under this Section 7 or Section 8 hereof (whether or not the indemnified party
is an actual or potential party thereto), unless (x) such settlement, compromise or judgment (i) includes an unconditional release of
the indemnified party from all liability arising out of such claim, investigation, action or proceeding and (ii) does not include a statement
as to or an admission of fault, culpability or any failure to act, by</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
on behalf of the indemnified party, and (y) the indemnifying party confirms in writing its indemnification obligations hereunder with
respect to such settlement, compromise or judgment.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">8.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Contribution</U>. In order to provide for contribution
in circumstances in which the indemnification provided for in Section 7 is for any reason held to be unavailable from any indemnifying
party or is insufficient to hold harmless a party indemnified thereunder, the <FONT STYLE="letter-spacing: -0.05pt">Company and the Underwriters
</FONT>shall contribute to the aggregate losses, claims, damages, liabilities and expenses of the nature contemplated by such indemnification
provision (including any investigation, legal and other expenses incurred in connection with, and any amount paid in settlement of, any
action, suit or proceeding or any claims asserted, but after deducting in the case of losses, claims, damages, liabilities and expenses
suffered by the Company, any contribution received by the Company from Persons, other than the Underwriters, who may also be liable for
contribution, including Persons who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act, officers of the Company who signed the Registration Statement and directors of the Company) as incurred to which the Company and
one or more of the Underwriters may be subject, in such proportions as is appropriate to reflect the relative benefits received by the
Company and the Underwriters from the Offering or, if such allocation is not permitted by applicable law, in such proportions as are
appropriate to reflect not only the relative benefits referred to above but also the relative fault of the Company and the Underwriters
in connection with the statements or omissions which resulted in such losses, claims, <FONT STYLE="letter-spacing: -0.05pt">damages,
liabilities</FONT> or expenses, as well as any other relevant equitable considerations. The relative benefits received by the Company
and the Underwriters shall be deemed to be in the same proportion as (x) the total proceeds from the Offering (net of underwriting discounts
and commissions but before deducting expenses) received by the Company bears to (y) the underwriting discount or commissions received
by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The relative fault of each of the Company
and of the Underwriters shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters
and the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 8 were determined
by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which
does not take account of the equitable considerations referred to above in this Section. The aggregate amount of losses, liabilities,
claims, damages and expenses incurred by an indemnified party and referred to above in this Section 8 shall be deemed to include any
legal or other expenses <FONT STYLE="letter-spacing: -0.05pt">reasonably</FONT> incurred by such indemnified party in investigating,
preparing or defending against any litigation, or any investigation or proceeding by any judicial, regulatory or other legal or <FONT STYLE="letter-spacing: -0.05pt">governmental
</FONT>agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission
or alleged omission. Notwithstanding the <FONT STYLE="letter-spacing: -0.05pt">provisions of this Section 8: (i)</FONT> no Underwriter
shall be required to contribute any amount in excess of the aggregate discounts and commissions applicable to the Securities underwritten
by it and distributed to the public and (ii) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. For purposes
of this Section 8, each Person, if any, who controls an Underwriter within the meaning of Section 15 of the Securities Act</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
Section 20 of the Exchange Act shall have the same rights to contribution as such Underwriter, and each Person, if any, who controls
the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, each officer of the Company who
shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as the Company,
subject in each case to clauses (i) and (ii) of the immediately preceding sentence. Any party entitled to contribution will, promptly
after receipt of notice of commencement of any action, suit or proceeding against such party in respect of which a claim for contribution
may be made against another party or parties, notify each party or parties from whom contribution may be sought, but the omission to
so notify such party or parties shall not relieve the party or parties from whom contribution may be sought from any obligation it or
they may have under this Section 8 or otherwise. The obligations of the Underwriters to contribute pursuant to this Section 8 are several
in proportion to the respective number of Securities to be purchased by each of the Underwriters hereunder and not joint.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">9.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Underwriter Default</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any Underwriter or Underwriters shall default in
its or their obligation to purchase Firm Shares hereunder, and if the securities with respect to which such default relates (the &ldquo;<B>Default
Securities</B>&rdquo;) do not (after giving effect to arrangements, if any, made by the Representative pursuant to subsection (b) below)
exceed in the aggregate 10% of the number of Firm Shares, each non-defaulting Underwriter, acting severally and not jointly, agrees to
purchase from the Company that number of Default Securities that bears the same proportion of the total number of Default Securities
then being purchased as the number of Firm Shares set forth opposite the name of such Underwriter on <U>Schedule I</U> hereto bears to
the aggregate number of Firm Shares set forth opposite the names of the non-defaulting Underwriters, subject, however, to such adjustments
to eliminate fractional shares as the Representative in its sole discretion shall make.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that the aggregate number of Default Securities
exceeds 10% of the number of Firm Shares, the Representative may in its discretion arrange for themselves or for another party or parties
(including any non-defaulting Underwriter or Underwriters who so agree) to purchase the Default Securities on the terms contained herein.
In the event that within 48 hours after such a default the Representative does not arrange for the purchase of the Default Securities
as provided in this Section 9, this Agreement shall thereupon terminate, without liability on the part of the Company with respect thereto
(except in each case as provided in Sections 5, 7, 8, 9 and 11(d)) or the Underwriters, but nothing in this Agreement shall relieve a
defaulting Underwriter or Underwriters of its or their liability, if any, to the other Underwriters and the Company for damages occasioned
by its or their default hereunder.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">In the</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">event
that any Default Securities are to be purchased by the non-defaulting Underwriters, or are to be purchased by another party or parties
as aforesaid, the Representative or the Company shall have the right to postpone the Closing Date for a period, not exceeding five (5)
Business Days, in order to effect whatever changes may thereby be necessary in the Registration Statement or the Prospectus or in any
other documents and arrangements, and the Company agrees to file promptly any amendment or supplement to the Registration Statement or
the Prospectus which, in the reasonable opinion of Underwriters&rsquo; Counsel, may thereby be made necessary or advisable. The term
&ldquo;Underwriter&rdquo; as used in this Agreement shall include</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any party
substituted under this Section 9 with like effect as if it had originally been a party to this Agreement with respect to such Firm Shares.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">10.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Survival of Representations and Agreements</U>. All
representations and warranties, covenants and agreements of the Company and the Underwriters contained in this Agreement or in certificates
of officers of the Company submitted pursuant hereto, including the agreements contained in Sections 5, 10, 14 and 15, the indemnity
agreements contained in Section 7 and the contribution agreements contained in Section 8 hereof, shall remain operative and in full force
and effect regardless of any investigation made by or on behalf of any Underwriter or any controlling Person thereof or by or on behalf
of the Company, any of its officers and directors or any controlling Person thereof, and shall survive delivery of and payment for the
Securities to and by the Underwriters. The representations contained in Section 2 hereof and the covenants and agreements contained in
Sections 5, 7, 8, this Section 10 and Sections 12, 13, 14 and 15 hereof shall survive any termination of this Agreement, including termination
pursuant to Section 9 or 11 hereof. The representations and covenants contained in Sections 2, 3 and 4 hereof shall survive termination
of this Agreement if any Securities are purchased pursuant to this Agreement.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">11.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Effective Date of Agreement; Termination</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Agreement shall become effective upon the later
of: (i) receipt by the Representative and the Company of notification of the effectiveness of the Registration Statement or (ii) the
execution of this Agreement. Notwithstanding any termination of this <FONT STYLE="letter-spacing: -0.05pt">Agreement, the provisions
</FONT>of this Section 11 and of Sections 5, 7, 8, 12, 13, 14 and 15, inclusive, shall remain in full force and effect at all times after
the execution hereof. If this Agreement is terminated after any Securities have been purchased hereunder, the provisions of Sections
2, 3 and 4 hereof shall survive termination of this Agreement.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Representative shall have the right to terminate
this Agreement at any time prior to the consummation of the Closing if: (i) any domestic or international event or act or occurrence
has materially disrupted, or in the opinion of the Representative will in the immediate future materially disrupt, the market for the
Company&rsquo;s securities or securities in general; or (ii) trading on the New York Stock Exchange or the Nasdaq Stock Market shall
have been suspended or been made subject to material limitations, or minimum or maximum prices for trading shall have been fixed, or
maximum ranges for prices for securities shall have been required, on the New York Stock Exchange or the Nasdaq Stock Market or by order
of the <FONT STYLE="letter-spacing: -0.05pt">Commission,</FONT> FINRA or any other governmental authority having jurisdiction; or (iii)
a banking moratorium has been declared by any state or federal authority or if any material disruption in commercial banking or securities
settlement or clearance services shall have occurred; (iv) any downgrading shall have occurred in the Company&rsquo;s corporate credit
rating or the rating accorded the Company&rsquo;s debt securities by any &ldquo;nationally recognized statistical rating organization&rdquo;
(as defined for purposes of Rule 436(g) under the Securities Act) or if any such organization shall have been publicly announced that
it has under surveillance or review, with material negative implications, its rating of any of the Company&rsquo;s debt securities; or
(v) (A) there shall have occurred any outbreak or escalation of hostilities or acts of terrorism involving the United States or there
is a declaration of a national emergency or war by the United States, excluding a national emergency declared related to the COVID-19
pandemic, or (B) there shall have been any other calamity or crisis or any change in political, financial or economic</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions
if the effect of any such event in (A) or (B), in the judgment of the Representative, is so material and adverse that such event makes
it impracticable or inadvisable to proceed with the offering, sale and delivery of the Firm Shares on the terms and in the manner contemplated
by the Prospectus.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(c)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any notice of termination pursuant to this Section 11
shall be in writing.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(d)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If this Agreement shall be terminated prior to the Closing
Date pursuant to any of the provisions hereof or if the sale of the Securities provided for herein is not consummated because any condition
to the obligations of the Underwriters set forth herein is not satisfied or <FONT STYLE="letter-spacing: -0.05pt">because</FONT> of any
refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof, the Company
will, subject to demand by the Representative, reimburse the Underwriters for those out-of-pocket expenses (including the reasonable
fees and expenses of Underwriters&rsquo; Counsel), actually incurred by the Underwriters in connection herewith up to $125,000, less
the Advance previously paid.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">12.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>. All communications hereunder, except
as may be otherwise specifically provided herein, shall be in writing, and:</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if sent to the Representative or any Underwriter, shall
be mailed, delivered, or faxed and confirmed in writing, to:</FONT></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maxim
Group LLC</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">405
Lexington Avenue</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10174</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Clifford A. Teller, Executive Managing Director of Investment Banking,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
212-895-3555</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to Underwriters&rsquo; Counsel at:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loeb
&amp; Loeb LLP 345 Park Avenue</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10154 Attention: Mitchell Nussbaum, Esq.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
212-407-4990</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000; letter-spacing: -0.05pt">(b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if sent to the Company, shall be mailed, delivered,
or faxed and confirmed in writing to the Company and its counsel at the addresses set forth in the Registration Statement.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">13.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Parties; Limitation of Relationship</U>. This Agreement
shall inure solely to the benefit of, and shall be binding upon, the Underwriters, the Company and the controlling Persons, directors,
officers, employees and agents referred to in Sections 7 and 8 hereof, and their respective successors and assigns, and no other Person
shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement
or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive
benefit of the parties hereto and said controlling Persons and their respective successors, officers, directors, heirs and legal representative,
and it is not for the benefit</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">of
any other Person. The term &ldquo;successors</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and assigns&rdquo;
shall not include a purchaser, in its capacity as such, of Securities from any of the Underwriters.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">14.&nbsp;
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing Law;</U> This Agreement shall be governed
by and construed in accordance with the laws of the State of New York without regard to conflict of laws principles.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">15.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Submission to Jurisdiction, Etc</U><I>.</I> The Company
hereby submits to the non-exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan, The City
<FONT STYLE="letter-spacing: -0.05pt">of New York in any suit</FONT> or proceeding arising out of or relating to this Agreement, the
Registration Statement, the Prospectus and the transactions contemplated hereby. The parties hereby irrevocably and unconditionally waive
any objection to the laying of venue of any lawsuit, action or other proceeding in such courts, and hereby further irrevocably and unconditionally
waive and agree not to plead or claim in any such court that any such lawsuit, action or other proceeding brought in any such court has
been brought in an inconvenient forum. To the extent that the Company has or hereafter may acquire any immunity (on the grounds of sovereignty
or otherwise) from the jurisdiction of any court or from any legal process with respect to itself or its property, the Company irrevocably
waives, to the fullest extent permitted by law, such immunity in respect of any such suit, action or proceeding. EACH OF THE COMPANY
(ON BEHALF OF ITSELF AND, TO THE FULLEST EXTENT PERMITTED BY LAW, ON BEHALF OF ITS RESPECTIVE EQUITY HOLDERS AND CREDITORS) HEREBY WAIVES
ANY RIGHT IT <FONT STYLE="letter-spacing: -0.05pt">MAY HAVE TO A TRIAL BY</FONT> JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING OUT
OF OR IN CONNECTION WITH THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, THE REGISTRATION STATEMENT, AND THE PROSPECTUS.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">16.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Entire Agreement</U>. This Agreement, together with
the exhibits, schedules and annexes attached hereto and as the same may be amended from time to time in accordance with the terms hereof,
constitutes the entire agreement of the parties to this Agreement and supersedes all prior or contemporaneous written or oral agreements,
understandings, promises and negotiations with respect to the subject matter hereof.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">17.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severability</U>. If any term or provision of this
Agreement or the performance thereof shall be invalid or unenforceable to any extent, such invalidity or unenforceability shall not affect
or render invalid or unenforceable any other provision of this Agreement and this Agreement shall be valid and enforced to the fullest
extent permitted by law.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">18.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amendment</U>. This Agreement may only be amended
by a written instrument executed by each of the parties hereto.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">19.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Waiver, etc</U>. The failure of any of the parties
hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such provision,
nor to in any way effect the validity of this Agreement or any provision hereof or the right of any of the parties hereto to thereafter
enforce each and every provision of this Agreement. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions
of this <FONT STYLE="letter-spacing: -0.05pt">Agreement shall be effective</FONT> unless set forth in a written instrument executed by
the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach,</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">20.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No Fiduciary Relationship</U>. The Company hereby
acknowledges that the Underwriters are acting solely as underwriters in connection with the offering of the Company&rsquo;s Securities.
The Company further acknowledges that the Underwriters are acting pursuant to a contractual relationship created solely by this Agreement
entered into on an arm&rsquo;s length basis and in no event do the parties intend that the Underwriters act or be responsible as a fiduciary
to the Company, its management, shareholders, creditors or any other person in connection with any activity that the Underwriters may
undertake or have undertaken in furtherance of the offering of the Company&rsquo;s Securities, either before or after the date hereof.
The Underwriters hereby expressly disclaim any fiduciary or similar obligations to the Company, either in connection with the transactions
contemplated by this Agreement or any matters leading up to such transactions, and the Company hereby confirms its understanding and
agreement to that effect. The Company hereby further <FONT STYLE="letter-spacing: -0.05pt">confirms</FONT> its understanding that no
Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company with respect to the Offering contemplated hereby
or the process leading thereto, including any negotiation related to the pricing of the Securities; and the Company has consulted its
own legal and financial advisors to the extent it has deemed appropriate in connection with this Agreement and the Offering. The Company
and the Underwriters agree that they are each responsible for making their own independent judgments with respect to any such transactions,
and that any opinions or views expressed by the Underwriters to the Company regarding such transactions, including but not limited to
any opinions or views with respect to the price or market for the Company&rsquo;s securities, do not constitute advice or recommendations
to the Company. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have
against the Underwriters with respect to any breach or alleged breach of any fiduciary or similar duty to the Company in connection with
the transactions contemplated by this Agreement or any matters leading up to such transactions.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><FONT STYLE="color: #010000">21.&nbsp;
</FONT><U>Judgment Currency</U><I>. </I>The obligation of the Company in respect of any sum due to any Underwriter under this Agreement
shall, notwithstanding any judgment in a currency other than U.S. dollars (the &ldquo;<B>Judgment Currency</B>&rdquo;), not be discharged
until the first Business Day, following <FONT STYLE="letter-spacing: -0.05pt">receipt by such</FONT> Underwriter of any sum adjudged
to be so due in the Judgment Currency, on which (and only to the extent that) such Underwriter may in accordance with normal banking
procedures purchase U.S. dollars with the Judgment Currency; if the U.S. dollars so purchased are less than the sum originally due to
such Underwriter hereunder, the Company agrees, as a separate obligation and notwithstanding any such judgment, to indemnify such Underwriter
against such loss. If the U.S. dollars so purchased are greater than the sum originally due to such Underwriter hereunder, such Underwriter
agrees to pay to the Company an amount equal to the excess of the U.S. dollars so purchased over the sum originally due to such Underwriter
hereunder.</P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">22.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Counterparts</U>. This Agreement may be executed
in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one
and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or other electronic transmission shall constitute
valid and sufficient delivery thereof.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">23.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Headings</U>. The headings herein are inserted for
convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">24.&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Time is of the Essence</U>. Time shall be of the
essence of this Agreement. As used herein, the term &ldquo;Business Day&rdquo; shall mean any day other than a Saturday, Sunday or any
day on which the major stock exchanges in New York, New York are not open for business.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Pages Follow]</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth your understanding, please so indicate in the space provided below for that purpose, whereupon this
letter shall constitute a binding agreement among us.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly
yours,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOCIETY PASS INCORPORATED</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: <U>/s/ Dennis Nguyen</U></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Dennis Nguyen</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
by the Representative, acting for themselves and as Representative of the Underwriters named on <U>Schedule I</U> attached hereto, as
of the date first written above:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAXIM GROUP
LLC&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
______________________</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Clifford A. Teller</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
Executive Managing Director,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Banking</FONT></P>





















<P STYLE="font: 15pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[UNDERWRITING
AGREEMENT SIGNATURE PAGE]</FONT></P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/95% Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth your understanding, please so indicate in the space provided below for that purpose, whereupon this
letter shall constitute a binding agreement among us.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly
yours,</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOCIETY PASS INCORPORATED</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: ___________________</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Dennis Nguyen</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif"></P>



<P STYLE="font: bold 12pt/96% Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
by the Representative, acting for themselves and as Representative of the Underwriters named on <U>Schedule I</U> attached hereto, as
of the date first written above:</FONT></P>

<P STYLE="font: bold 12pt/96% Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAXIM
                                            GROUP LLC&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
<U>/s/ Clifford A. Teller</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Clifford A. Teller</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
Executive Managing Director,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
Banking</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
I</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 50%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42%; border: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 13.15pt; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of <FONT STYLE="letter-spacing: -0.05pt">Underwriter</FONT></B></FONT></TD>
    <TD STYLE="width: 58%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt/13.8pt Times New Roman, Times, Serif; padding-right: 23.15pt; padding-left: 5.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Firm Shares Being Purchased</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maxim
                                            Group LLC</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,888,889</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center; border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,888,889</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
II</B></FONT></P>

<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Parties</B></FONT></P>


<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>











<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis
Nguyen</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raynauld
Liang</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cham Ngo</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yuki Phan</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shashi
Kant Mishra</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tan Bien
Kiat</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeremy
Miller</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linda Cutler</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Mackay</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maroon
Capital Limited</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gopher
Limited</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blue Jay
Capital Limited</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis
Nguyen</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raynauld
Liang</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tan Bien
Kiat</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">Thang
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nguyen</FONT></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>



<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
III</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Free
Writing Prospectus</B></FONT></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
IV&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries</FONT></P>

<P STYLE="font: 5.5pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 45%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT></TD><TD STYLE="width: 10%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; width: 43%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Society Technology LLC</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. SoPa Technology Pte Ltd.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. SoPa Cognitive Analytics
    Private Limited</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">India</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Sopa Technology Co Ltd</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vietnam</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. HOTTAB Pte Ltd</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. HOTTAB Vietnam Co Ltd</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vietnam</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. HOTTAB Asset Vietnam Co
    Ltd</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vietnam</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>




<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
I</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Lock-Up Agreement<B>&nbsp;</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______,
2021</FONT></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maxim
Group LLC</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">405
Lexington Avenue</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10174</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that Maxim Group LLC (the &ldquo;<B>Representative</B>&rdquo;) proposes to enter into an Underwriting Agreement
(the &ldquo;<B>Underwriting Agreement </B>&ldquo;) with Society Pass Incorporated, a corporation incorporated under the laws of the State
of Nevada (the &ldquo;<B>Company</B>&rdquo;), providing for the public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of shares
of common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;).</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
induce the Representative to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without
the prior written consent of the Representative, the undersigned will not, during the period commencing on the date of the Underwriting
Agreement and ending one hundred eighty (180) days after such date (the &ldquo;<B>Lock-Up Period</B>&rdquo;), (1) offer, pledge, sell,
contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities
convertible into or exercisable or exchangeable for shares of Common Stock, whether now owned or hereafter acquired by the undersigned
or with respect to which the undersigned has or hereafter acquires the power of disposition (collectively, the &ldquo;<B>Lock-Up Securities</B>&rdquo;);
(2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Lock-Up Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up
Securities, in cash or otherwise; (3) make any demand for or exercise any right with <FONT STYLE="letter-spacing: -0.05pt">respect to
the registration</FONT> of any Lock-Up Securities; or (4) publicly disclose the intention to make any offer, sale, pledge or disposition,
or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up Securities. Notwithstanding the foregoing,
and subject to the conditions below, the undersigned may transfer Lock-Up Securities without the prior written consent of the Representative
in connection with (a) transactions relating to Lock-Up Securities acquired in open market transactions after the completion of the Public
Offering; <U>provided</U> that no filing under Section 16(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;), shall be required or shall be voluntarily made in connection with subsequent sales of Lock- Up Securities acquired in
such open market transactions during the Lock-Up Period; (b) transfers of Lock-Up Securities (i) as a <I>bona fide </I>gift, by will
or intestacy, (ii) by operation of law, such as pursuant to a qualified domestic order or as required by a divorce settlement; (iii)
to a family member or trust for the benefit of a family member (for purposes of this lock-up agreement, &ldquo;family member&rdquo; means
any relationship by blood, marriage or adoption, not more remote than</FONT></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">first
cousin); (iv) securities obtained pursuant to the Company&rsquo;s 2021 Equity Incentive Plan; or (v) or pursuant to a merger, consolidation,
share exchange or other transaction initiated by and involving the Company; (c) transfers of Lock-Up Securities to a charity or educational
institution; or (d) if the undersigned, directly or indirectly, controls a corporation, partnership, limited liability company or other
business entity, any transfers of Lock-Up Securities to any shareholder, partner <FONT STYLE="letter-spacing: -0.05pt">or member of,
or owner</FONT> of similar equity interests in, the undersigned, as the case may be; <U>provided</U> that in the case of any transfer
pursuant to the foregoing clauses (b) (except for (b)(ii) and (b)(iv) above), (c) or (d), (x) any such transfer shall not involve a disposition
for value, (y) each transferee shall sign and deliver to the Representative a lock-up agreement substantially in the form of this lock-up
agreement and (z) no filing under Section 16(a) of the Exchange Act shall be required or shall be voluntarily made during the Lock-Up
Period. The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and
registrar against the transfer of the undersigned&rsquo;s Lock-Up Securities except in compliance with this lock-up agreement.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is an officer or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be equally
applicable to any Securities that the undersigned may purchase in the Public Offering; (ii) the Representative agrees that, at least
three (3) Business Days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer
of Lock-Up Securities, the Representative will notify the Company of the impending release or waiver; and (iii) the Company has agreed
in the Underwriting Agreement to announce the impending release or waiver by press release through a major news service at least two
(2) Business Days before the effective date of the release or waiver. Any release or waiver granted by <FONT STYLE="letter-spacing: -0.05pt">the
Representative</FONT> hereunder to any such officer or director shall only be effective two (2) Business Days after the publication date
of such press release. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer
of Lock-Up Securities not for consideration and (b) the transferee has agreed in writing to be bound by the same terms described in this
lock-up agreement to the extent and for the duration that such terms remain in effect at the time of such transfer.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
provision in this lock-up agreement shall be deemed to restrict or prohibit the exercise, exchange or conversion by the undersigned of
any securities exercisable or exchangeable for or convertible into shares of Common Stock, as applicable; <U>provided</U> that the undersigned
does not transfer the Common Stock acquired on such exercise, exchange or conversion during the Lock- Up Period, unless otherwise permitted
pursuant to the terms of this lock-up agreement. In addition, no provision herein shall be deemed to restrict or prohibit the entry into
or modification of a so- called &ldquo;10b5-1&rdquo; plan at any time (other than the entry into or modification of such a plan in such
a manner as to cause the sale of any Lock-Up Securities within the Lock-Up Period) or a sale of 100% of the Company&rsquo;s outstanding
Common Stock</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation
of the Public Offering. The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the
undersigned&rsquo;s heirs, legal representatives, successors and assigns.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that, if the Underwriting Agreement is not executed by October 31, 2021, or if the Underwriting Agreement (other
than the provisions thereof which</FONT></P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">survive
termination) shall terminate or be terminated prior to payment for and delivery of the securities to be sold thereunder, then this lock-up
agreement shall be void and of no further force or effect.</FONT></P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only
be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Representative.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name - Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Signatory, in the case of entities - Please
  Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title of Signatory, in the case of entities - Please
  Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>










<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
II<B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF U.S. SECURITIES COUNSEL OPINION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Intentionally
Omitted.]</FONT></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
III</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF NEVADA COUNSEL OPINION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Intentionally
Omitted.]</FONT></P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14.5pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
IV</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Opinion of Vietnamese Counsel</B></FONT></P>

<P STYLE="text-align: center; font: 12pt/186% Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none">[Intentionally
Omitted.]</FONT></P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
VI</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
of Representative&rsquo;s Warrant</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE COMMENCEMENT OF SALES OF THE OFFERING TO
ANYONE OTHER THAN (I) MAXIM GROUP LLC, OR (II) ANY SUCCESSOR, OFFICER, MANAGER OR MEMBER OF MAXIM GROUP LLC (OR TO OFFICERS, MANAGERS
OR MEMBERS OF ANY SUCH SUCCESSOR OR MEMBER); OR (III)&nbsp; TO MEMBERS OF THE UNDERWRITING SYNDICATE OR SELLING GROUP. (SEE SECTION 4(a).</FONT></P>



<P STYLE="font: bold 12pt/186% Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMON
STOCK PURCHASE WARRANT</FONT></P>

<P STYLE="font: bold 12pt/186% Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SOCIETY
PASS INCORPORATED</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: top; width: 43%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [ ]</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 46%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
    Issuance Date: [ ], 2021</FONT></TD></TR>
  </TABLE>




<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">THIS
COMMON</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;)
certifies that, for value received, Maxim Partners LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and
subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 8, 2022 (the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on November 8, 2026 (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Society Pass Incorporated, a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 144,445 shares of Common Stock (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein <FONT STYLE="letter-spacing: -0.05pt">shall have the
meanings</FONT> set forth in that certain Underwriting Agreement (the &ldquo;<U>Agreement</U>&rdquo;), dated November 8, 2021 by and
between the Company and Maxim Group, LLC, as representative of the several underwriters.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">a)&nbsp;
<U>Exercise of Warrant</U>. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise of the purchase
rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on
or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise
in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the</FONT></P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Standard
Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise Price</U>. The exercise price per share
of Common Stock under this Warrant shall be $9.90 (which is 110% of the offering price per share of Common Stock in the offering contemplated
by the Agreement) (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cashless Exercise</U>. If at the time of exercise
hereof there is no effective registration statement registering the Warrant Shares, or the prospectus contained therein is not available
for the issuance of the Warrant Shares to the Holder, then, provided that the Trading Price, as defined below, is equal to or greater
than the Exercise Price, on the Termination Date, this Warrant may also be exercised, in whole or in part, at such time by means of a
&ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained
by dividing [(A-B) (X)] by (A), where:</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both <FONT STYLE="letter-spacing: -0.05pt">executed and delivered</FONT> pursuant to Section 2(a) hereof on a day that
is not a Trading <FONT STYLE="letter-spacing: -0.05pt">Day or (2) both</FONT> executed and delivered pursuant to Section 2(a) hereof
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(64) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported
by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed
during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2)
hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant</FONT></P>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading
Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading
hours&rdquo; on such Trading Day (such applicable price for (a), the &ldquo;Trading Price&rdquo;);</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised and the holding period of the Warrants
being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to
this Section 2(c).</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is traded on OTCQB or OTCQX, the volume weighted
average sales price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the &ldquo;Pink
Sheets&rdquo; published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common
Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New <FONT STYLE="letter-spacing: -0.05pt">York City time)),</FONT> (b) if the Common Stock is
traded on OTCQB or OTCQX , the volume weighted average sales price of the shares of Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported in the &ldquo;Pink Sheets&rdquo; published by OTC Markets Group, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
that the Trading Price is equal to or greater than the Exercise Price, on the Termination Date, this Warrant shall be automatically exercised
via cashless exercise pursuant to this Section 2(c).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder, or (B) if there is no effective registration statement and the Warrant is exercised via cashless exercise
at a time when such Warrant Shares would be eligible for resale under Rule 144 by a non-affiliate of the Company, such Warrant Shares
are delivered to Holder&rsquo;s broker, and the Company receives a statement from Holder&rsquo;s broker that it has received instructions
to sell the Warrant Shares or that it would take responsibility that the sales of the Warrant Shares will only be made if the Warrant
Shares are eligible to be sold under Rule 144, and otherwise by physical delivery <FONT STYLE="letter-spacing: -0.05pt">of a certificate,
</FONT>registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to
which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of <FONT STYLE="letter-spacing: -0.05pt">Exercise
</FONT>by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii)
one (1) Trading Day after delivery of the aggregate Exercise Price to the Company (unless the Warrant is exercised <FONT STYLE="letter-spacing: -0.05pt">via
cashless exercise) and (iii)</FONT> the number of Trading Days comprising the Standard <FONT STYLE="letter-spacing: -0.05pt">Settlement
</FONT>Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the <FONT STYLE="letter-spacing: -0.05pt">Warrant Shares</FONT>
subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages
and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of
the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated
damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
rescinds such exercise. The Company agrees to use commercially reasonable efforts to maintain a transfer agent that is a participant
in the FAST program so long as this <FONT STYLE="letter-spacing: -0.05pt">Warrant remains outstanding</FONT> and exercisable. As used
herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading</FONT></P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Days, on
the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&nbsp;
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&nbsp;
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of Warrants with an aggregate sale price giving rise to such purchase obligation of $10,000 of shares of Common Stock, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy- In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific <FONT STYLE="letter-spacing: -0.05pt">performance and/or</FONT> injunctive
relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required
pursuant to the terms hereof.</FONT></P>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.&nbsp;
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round down to the next whole share.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.&nbsp;
<FONT STYLE="letter-spacing: -0.05pt"><U>Charges, Taxes and Expenses</U>. </FONT>Issuance of Warrant Shares shall be made without charge
to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which
transfer taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such
name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued
in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached
hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse
it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice
of Exercise and all fees to the Depository Trust Company (or another established <FONT STYLE="letter-spacing: -0.05pt">clearing corporation
</FONT>performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.&nbsp;
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">e)&nbsp;
<U>Holder&rsquo;s Exercise </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations</FONT></U><FONT STYLE="font: 10pt Times New Roman, Times, Serif">.
The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant,
pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable
Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and <FONT STYLE="letter-spacing: -0.05pt">any other Persons
acting</FONT> as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall <FONT STYLE="letter-spacing: -0.05pt">include
the number of shares of</FONT> Common Stock issuable upon exercise of this Warrant with respect to which such determination is being
made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or non-converted portion of any other securities of the Company (including, without limitation, any other Common Stock
equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e),
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the</FONT></P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of <FONT STYLE="letter-spacing: -0.05pt">Common
Stock then</FONT> outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties
since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock Dividends and Splits</U>. If the Company, at
any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on Common Stock
or any other equity or equity equivalent securities payable in shares of Common <FONT STYLE="letter-spacing: -0.05pt">Stock (which,</FONT>
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding Common
Stock into a smaller number of shares, or (iv) issues by reclassification of common Stock, any shares of capital stock of the Company,
then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common
Stock (excluding</FONT></P>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">treasury
shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock
outstanding immediately after such event, and the <FONT STYLE="letter-spacing: -0.05pt">number of shares issuable</FONT> upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any
adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re- classification.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsequent Rights Offerings</U>. In addition to any
adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock equivalents or rights
to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Stock (the &ldquo;<U>Purchase
Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase
Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, <FONT STYLE="letter-spacing: -0.05pt">including without limitation,
</FONT>the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of
such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for
the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Pro Rata Distributions</U>. During such time as this
Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its
assets) to holders of Common Stock, by way of return of capital or otherwise, other than cash (including, without limitation, any distribution
of stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of
arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then,
in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated
therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Common Stock
are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, to the extent that the Holder's right
to <FONT STYLE="letter-spacing: -0.05pt">participate in any such</FONT> Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">d)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fundamental Transaction</U>. If, at any time while
this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or <FONT STYLE="letter-spacing: -0.05pt">consolidation
</FONT>of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)
any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has
been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,
directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of
Persons whereby such other Person or group acquires more than 50% of the outstanding Common Stock (not including any <FONT STYLE="letter-spacing: -0.05pt">shres
of Common Stock</FONT> held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option,
exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the
date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, if the Fundamental Transaction is not within the Company's control,
including not approved by the Company's Board of Directors or the consideration is not in all stock of the Successor Entity, Holder shall
only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction,
the same</FONT></P>


<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">type
or form of consideration (and in the same proportion), at the Black Scholes Value (as defined below) of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction. &ldquo;<U>Black Scholes
Value</U>&rdquo; means the value of this Warrant based on the Black and Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate as of the Trading Day immediately
following the public announcement of the applicable Fundamental Transaction, (B) an expected volatility equal to the greater of 100%
and the 100 day volatility obtained from the HVT function on Bloomberg as of the Trading Day immediately following the public announcement
of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the
sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such
Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately prior to the public announcement of such Fundamental Transaction
and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a remaining option time equal to
the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date. The payment
of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the Holder&rsquo;s
election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is <FONT STYLE="letter-spacing: -0.05pt">not the survivor</FONT> (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to <FONT STYLE="letter-spacing: -0.05pt">the
consummation of</FONT> such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon
the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this <FONT STYLE="letter-spacing: -0.05pt">Warrant and the other Transaction Documents</FONT> with the same effect
as if such Successor Entity had been named as the Company herein.</FONT></P>


<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">e)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Calculations</U>. All calculations under this Section
3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number
of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock
(excluding treasury shares, if any) issued and outstanding.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">f)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notice to Holder</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant <FONT STYLE="letter-spacing: -0.05pt">to any provision
</FONT>of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise
Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
requiring such adjustment.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;
<FONT STYLE="letter-spacing: -0.05pt"><U>Notice to Allow Exercise </U></FONT><U>by Holder</U>. If (A) the Company shall declare a dividend
(or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend
on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants
to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company
shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a
party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the shares
of Common Stock are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by
facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company,
at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which
a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken,
the date as of which the holders of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants
are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange
their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale,
transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not
affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during
the period commencing on the date of such notice</FONT></P>


<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transferability</U>. Pursuant to FINRA Rule 5110(g)(1)
and the Agreement, neither <FONT STYLE="letter-spacing: -0.05pt">this Warrant nor</FONT> any Warrant Shares issued upon exercise of this
Warrant shall be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put
or call transaction that would result in the effective economic disposition of the securities by any person for a period of one hundred
eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant
is being issued, except the transfer of any security:</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(i)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by operation of law or by reason of reorganization of
the Company;</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(ii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to any FINRA member firm participating in the offering
and the officers and partners thereof, if all securities so transferred remain subject to the lock-up restriction in this Section 4(a)
for the remainder of the time period;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(iii)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the aggregate amount of securities of the Company
held by the Holder or related person do not exceed 1% of the securities being offered;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(iv)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that is beneficially owned on a pro-rata basis by all
equity owners of an investment fund, provided that no participating member manages or otherwise directs investments by the fund, and
participating members in the aggregate do not own more than 10% of the equity in the fund; or</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(v)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise or conversion of any security, if all securities
received remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing restrictions, compliance with any applicable securities laws, and the <FONT STYLE="letter-spacing: -0.05pt">conditions
set forth in Section</FONT> 4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an
assignment form to the <FONT STYLE="letter-spacing: -0.05pt">Company assigning</FONT> this Warrant in full. The Warrant, if properly
assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>New Warrants</U>. This Warrant may be divided or
combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying
the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance
with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a
new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants
issued on transfers or exchanges shall be dated the Original Issuance Date of this Warrant and shall be identical with this Warrant except
as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrant Register</U>. The Company shall register
this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;), in the name
of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner
hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to
the contrary.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">d)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representation by the Holder</U>. The Holder, by
the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant
Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant or Warrant
Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered
or exempted under the Securities Act.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5.</U> Registration Rights</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">a)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Demand Registration.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;
<U>Grant of Right</U>. The Company, upon written demand (&ldquo;<U>Initial Demand Notice</U>&rdquo;) of the Holder(s) of at least 51%
of the Warrant Shares (&ldquo;<U>Majority Holders</U>&rdquo;), agrees to register on two occasions only (each, a &ldquo;<U>Demand Registration</U>&rdquo;)
under the Securities Act all or any portion of the Warrant Shares requested by the Majority Holders in the Initial Demand Notice (the
&ldquo;<U>Registrable Securities</U>&rdquo;). On such occasion, the Company will file a registration statement covering the Registrable
Securities within 60 days after receipt of the Initial Demand Notice and to have such registration statement declared effective as soon
as possible thereafter. A demand for registration may be made at any time during which the Majority Holders hold any of the Warrant Shares.
Notwithstanding the foregoing, the Company shall not be required to effect a registration pursuant to this Section 5 a): (A) with respect
to securities that are not Registrable Securities; (B) during any Scheduled Black-Out Period; (C) if the aggregate offering price of
the Registrable Securities to be offered is less than $250,000, unless the Registrable Securities to be offered constitute all of the
then-outstanding Registrable Securities; or (D) within 180 days after the effective date of a prior registration in respect of the Common
Stock, including a Demand Registration (or, in the event that Holders were prevented from including any Registrable Securities requested
to be included in a Piggyback Registration pursuant to Section 5(b), within 90 days after the effective date of such prior registration
in respect of the Common</FONT></P>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock.
For purposes of this Agreement, a &ldquo;<U>Scheduled Black-Out Period</U>&rdquo; shall means the periods from and including the day
that is ten days prior to the last day of a fiscal quarter of the Company to and including the day that is two days after the day on
which the Company publicly releases its earnings for such fiscal quarter. The Initial Demand Notice shall specify the number of shares
of Registrable Securities proposed to be sold and the intended method(s) of distribution thereof. The Company will notify all holders
of the Warrant Shares of the demand within ten days from the date of the receipt of any such Initial Demand Notice. Each holder of the
Warrant Shares who wishes to include all or a portion of such holder&rsquo;s Warrant Shares in the Demand Registration (each such holder
including shares of Registrable Securities in such registration, a &ldquo;<U>Demanding Holder</U>&rdquo;) shall so notify the Company
within 15 days after the receipt by the holder of the notice from the Company. Upon any such request, the Demanding Holders shall be
entitled to have their Warrant Shares included in the Demand Registration. The term of the Demand Registration shall not be more than
five-years from the Effective Date.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Effective Registration</U>. A registration will not count as a Demand Registration until the registration statement filed with the
Commission with respect to such Demand Registration has been declared effective and the Company has complied with all of its obligations
under this Warrant with respect thereto.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&nbsp;
<U>Terms.</U> In connection with the first Demand Registration, the Company shall bear all fees and expenses attendant to registering
the Registrable Securities, including the reasonable expenses of one legal counsel selected by the Holders to represent them in connection
with the sale of the Registrable Securities. In connection with the second Demand Registration, the Holders shall bear all fees and expenses
attendant to registering the Registrable Securities including the reasonable expenses of the Company&rsquo;s legal counsel. The Company
agrees to qualify or register the Registrable Securities in such states as are reasonably requested by the Majority Holder(s); provided,
however, that in no event shall the Company be required to register the Registrable Securities in a state in which such registration
would cause (i) the Company to be obligated to qualify to do business in such state, or would subject the Company to taxation as a foreign
corporation doing business in such jurisdiction or (ii) the principal shareholders of the Company to be obligated to escrow their shares
of Common Stock of the Company. The Company shall cause any registration statement filed pursuant to the demand rights granted under
Section 5(a)(iii) to remain effective until all Registrable Securities are sold.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&nbsp;
Notwithstanding the foregoing, if the Board of Directors of the Company determines in its good faith judgment that the filing of a registration
statement in connection with a Demand Registration (i) would be seriously detrimental to the Company in that such registration would
interfere with a material corporate transaction or (ii) would require the disclosure of material non-public information concerning the
Company that at the time is not, in the good faith judgment of the Board of Directors, in the best interests of the Company to disclose
and is not, in</FONT></P>


<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
opinion of the Company&rsquo;s counsel, otherwise required to be disclosed, then the Company shall have the right to defer such filing
for the period during which such registration would be seriously detrimental under clause (i) or would require such disclosure under
clause (ii); provided, however, that (x) the Company may not defer such filing for a period of more than 90 days after receipt of any
demand by the Holders and (y) the Company shall not exercise its right to defer a Demand Registration more than once in any 12-month
period. The Company shall give written notice of its determination to the Holders to defer the filing and of the fact that the purpose
for such deferral no longer exists, in each case, promptly after the occurrence thereof.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">b)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Piggy-Back Registration.</U></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;
<U>Piggy-Back Rights</U>. If at any time during the five year period after the Effective Date, and the Registration Statement is no longer
effective, the Company proposes to file a registration statement under the Securities Act with respect to an offering of equity securities,
or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Company for its own
account or for shareholders of the Company for their account (or by the Company and by shareholders of the Company including, without
limitation, pursuant to Section 5(a)), other than a registration statement (i) filed in connection with any employee share option or
other benefit plan, (ii) for an exchange offer or offering of securities solely to the Company&rsquo;s existing shareholders, or (iii)
for a dividend reinvestment plan, then the Company shall (x) give written notice of such proposed filing to the holders of Registrable
Securities as soon as practicable but in no event less than ten days before the anticipated filing date, which notice shall describe
the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed
managing underwriter or underwriters, if any, of the offering, and (y) offer to the holders of Registrable Securities in such notice
the opportunity to register the sale of such number of Warrant Shares held by such holder (the &ldquo;<U>Piggy-Back Registrable Securities</U>&rdquo;),
as such holders may request in writing within five days following receipt of such notice (a &ldquo;<U>Piggy-Back Registration</U>&rdquo;).
The Company shall cause such Piggy-Back Registrable Securities to be included in such registration and shall use its commercially reasonable
efforts to cause the managing underwriter or underwriters of a proposed underwritten offering to permit the Piggy-Back Registrable Securities
requested to be included in a Piggy-Back Registration on the same terms and conditions as any similar securities of the Company and to
permit the sale or other disposition of such Piggy-Back Registrable Securities in accordance with the intended method(s) of distribution
thereof. All holders of Piggy-Back Registrable Securities proposing to distribute their securities through a Piggy-Back Registration
that involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the underwriter or underwriters
selected for such Piggy-Back Registration.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;
<U>Reduction of Offering</U>. If the managing underwriter or underwriters for a Piggy-Back Registration that is to be an underwritten
offering advises the</FONT></P>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
and the holders of Registrable Securities in writing that the dollar amount or number of shares of Common Stock which the Company desires
to sell, taken together with shares of Common Stock, if any, as to which registration has been requested pursuant to written contractual
arrangements with persons other than the holders of Piggy-Back Registrable Securities hereunder, the Piggy- Back Registrable Securities
as to which registration has been requested under this Section 5(b), and the shares of Common Stock, if any, as to which registration
has been requested pursuant to the written contractual piggy-back registration rights of other shareholders of the Company, exceeds the
maximum dollar amount or maximum number of shares that can be sold in such offering without adversely affecting the proposed offering
price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number
of shares, as applicable, the &ldquo;<U>Maximum Number of Shares</U>&rdquo;), then the Company shall include in any such registration:</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
If the registration is undertaken for the Company&rsquo;s account: (A) first, the Common Stock or other securities that the Company desires
to sell that can be sold without exceeding the Maximum Number of Shares; and (B) second, subject to the requirements of registration
rights granted by the Company prior to the date hereof, to the extent that the Maximum Number of Shares has not been reached under the
foregoing clause (A), up to the amount of shares of Common Stock or other securities that can be sold without exceeding the Maximum Number
of Shares, on a pro rata basis, from (i) Piggy-Back Registrable Securities as to which registration has been requested and (ii) the Common
Stock or other securities for the account of other persons that the Company is obligated to register pursuant to written contractual
piggy-back registration rights with such persons;</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
If the registration is a Demand Registration undertaken at the demand of holders of Registrable Securities, subject to the requirements
of registration rights granted by the Company prior to the date hereof, (A) first, the shares of Common Stock or other securities for
the account of the demanding persons that can be sold without exceeding the Maximum Number of Shares; (B) second, to the extent that
the Maximum Number of Shares has not been reached under the foregoing clause (A), the shares of Common Stock or other securities comprised
of Piggy-Back Registrable Securities, pro rata, as to which registration has been requested pursuant to the terms hereof that can be
sold without exceeding the Maximum Number of Shares; and (C) third, to the extent that the Maximum Number of Shares has not been reached
under the foregoing clauses (A) and (B), the shares of Common Stock or other securities for the account of other persons that the Company
is obligated to register pursuant to written contractual arrangements with such persons, that can be sold without exceeding the Maximum
Number of Shares.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&nbsp;
<U>Withdrawal</U>. Any holder of Piggy-Back Registrable Securities may elect to withdraw such holder&rsquo;s request for inclusion of
such Piggy-Back Registrable Securities in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw
prior to the effectiveness of the registration</FONT></P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">statement.
The Company (whether on its own determination or as the result of a withdrawal by persons making a demand pursuant to written contractual
obligations) may withdraw a registration statement at any time prior to the effectiveness of the registration statement. Notwithstanding
any such withdrawal, the Company shall pay all expenses incurred by the holders of Piggy-Back Registrable Securities in connection with
such Piggy-Back Registration as provided in Section 5(b)(iv).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&nbsp;
<U>Terms</U>. The Company shall bear all fees and expenses attendant to registering the Piggy-Back Registrable Securities, including
the expenses of one legal counsel selected by the Holders to represent them in connection with the sale of the Piggy-Back Registrable
Securities but the Holders shall pay any and all underwriting commissions related to the Piggy-Back Registrable Securities. In the event
of such a proposed registration, the Company shall furnish the then Holders of outstanding Piggy-Back Registrable Securities with not
less than fifteen days written notice prior to the proposed date of filing of such registration statement. Such notice to the Holders
shall continue to be given for each applicable registration statement filed (during the period in which the Warrant is exercisable) by
the Company until such time as all of the Piggy-Back Registrable Securities have been registered and sold. The Holders of the Piggy-Back
Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice, within ten days
of the receipt of the Company&rsquo;s notice of its intention to file a registration statement. The Company shall cause any registration
statement filed pursuant to the above &ldquo;piggyback&rdquo; rights to remain effective for at least nine (9) months from the date that
the Holders of the Piggy- Back Registrable Securities are first given the opportunity to sell all of such securities.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General Terms</U>. These additional terms shall relate
to registration under Sections 5(a) above:</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Indemnification</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(w)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company shall, to the fullest extent permitted by
applicable law, indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and
each person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act against
all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably incurred
in investigating, preparing or defending against litigation, commenced or threatened, or any claim whatsoever whether arising out of
any action between the underwriter and the Company or between the underwriter and any third party or otherwise) to which any of them
may become subject under the Act, the Exchange Act or otherwise, arising from such registration statement; <U>provided</U>, <U>however</U>,
that, with respect to any Holder of Registrable Securities, this indemnity shall not apply to any loss, liability, claim, damage or expense
to the extent arising out of an untrue statement or omission or alleged untrue statement or omission made in</FONT></P>


<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reliance
upon and in conformity with written information furnished to the Company by such Holder expressly for use in the registration statement
(or any amendment thereto), or any preliminary prospectus or the prospectus (or any amendment or supplement thereto).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(x)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Holder(s) of the Registrable Securities to be sold
pursuant to such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, its
officers and directors and each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20(a)
of the Exchange Act, against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other
expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which they may become subject
under the Act, the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors
or assigns, in writing, for specific inclusion in such registration statement(or any amendment thereto), or any preliminary prospectus
or the prospectus (or any amendment or supplement thereto).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(y)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each indemnified party shall give prompt notice to each
indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify
an indemnifying party shall not relieve the indemnifying party from any liability it may have under this Agreement, except to the extent
that the indemnifying party is prejudiced thereby. If it so elects, after receipt of such notice, an indemnifying party, jointly with
any other indemnifying parties receiving such notice, may assume the defense of such action with counsel chosen by it; <U>provided</U>,
<U>however</U>, that the indemnified party shall be entitled to participate in (but not control) the defense of such action with counsel
chosen by it, the reasonable fees and expenses of which shall be paid by such indemnified party, unless a conflict would arise if one
counsel were to represent both the indemnified party and the indemnifying party, in which case the reasonable fees and expenses of counsel
to the indemnified party shall be paid by the indemnifying party or parties. In no event shall the indemnifying party or parties be liable
for a settlement of an action with respect to which they have assumed the defense if such settlement is effected without the written
consent of such indemnifying party, or for the reasonable fees and expenses of more than one counsel for (i) the Company, its officers,
directors and controlling persons as a group, and (ii) the selling Holders and their controlling persons as a group, in each case, in
connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations
or circumstances; <U>provided</U>, <U>however</U>, that if, in the reasonable judgment of an indemnified party, a conflict of interest
may exist between such indemnified party and the Company or any other of such indemnified parties with respect to such claim, the indemnifying
party shall be obligated to pay the reasonable fees and expenses of such additional counsel.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(z)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the indemnification provided for in or pursuant to
Section 5(b)(i) is due in accordance with the terms hereof, but held by a court of competent jurisdiction to be unavailable</FONT></P>


<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
unenforceable in respect of any losses, claims, damages, liabilities or expenses referred to therein, then each applicable indemnifying
party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a
result of such losses, claims, damages, liabilities or expenses in such proportion as is appropriate to reflect the relative fault of
the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions which
result in such losses, claims, damages, liabilities or expenses as well as any other relevant equitable considerations. The relative
fault of the indemnifying party on the one hand and of the indemnified party on the other shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by the indemnifying party or by the indemnified party, and by such party&rsquo;s relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;
<U>Documents Delivered to Holders</U>. The Company shall furnish the initial Holder a signed counterpart, addressed to the initial Holder,
of (i) an opinion of counsel to the Company, dated the effective date of such registration statement (or, if such registration includes
an underwritten public offering, an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii)
if such registration statement is filed in connection of an underwritten public offering, a &ldquo;cold comfort&rdquo; letter dated the
effective date of such registration statement (or, if such registration includes an underwritten public offering, a letter dated the
date of the closing under the underwriting agreement) signed by the independent public accountants who have issued a report on the Company&rsquo;s
financial statements included in such registration statement, in each case covering substantially the same matters with respect to such
registration statement (and the prospectus included therein) and, in the case of such accountants&rsquo; letter, with respect to events
subsequent to the date of such financial statements, as are customarily covered in opinions of issuer&rsquo;s counsel and in accountants&rsquo;
letters delivered to underwriters in underwritten public offerings of securities.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&nbsp;
<U>Supplemental Prospectus</U>. Each Holder agrees, that upon receipt of any notice from the Company of the happening of any event as
a result of which the prospectus included in the registration statement, as then in effect, includes an untrue statement of a material
fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light
of the circumstances then existing, such Holder will immediately discontinue disposition of Registrable Securities pursuant to the registration
statement covering such Registrable Securities until such Holder&rsquo;s receipt of the copies of a supplemental or amended prospectus,
and, if so desired by the Company, such Holder shall deliver to the Company (at the expense of the Company) or destroy (and deliver to
the Company a certificate of such destruction) all copies, other than permanent file copies then in such Holder&rsquo;s possession, of
the prospectus covering such Registrable Securities current at the time of receipt of such notice. Immediately after discovering of such
an event which causes the prospectus included in the registration statement, as then in effect, includes an untrue statement of a material
fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light
of the circumstances then existing, the Company shall prepare and file, as soon as practicable, a supplement or amendment to the prospectus
so that such registration statement does not include any untrue statement of a material fact or omits to state a material fact required
to be stated therein or necessary to make the statements therein not</FONT></P>


<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">misleading
in light of the circumstances then existing and distribute such supplement or amendment to each Holder.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. Miscellaneous.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">a)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No Rights as Stockholder Until Exercise</U>. This
Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise
hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">b)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loss, Theft, Destruction or Mutilation of Warrant</U>.
The Company covenants that <FONT STYLE="letter-spacing: -0.05pt">upon</FONT> receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">c)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Saturdays, Sundays, Holidays, etc</U>. If the last
or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day,
then, such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorized Shares</U>.</FONT></P>





<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide <FONT STYLE="letter-spacing: -0.05pt">for the issuance</FONT> of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
provided herein <FONT STYLE="letter-spacing: -0.05pt">without violation</FONT> of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and non-assessable and free
from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of</FONT></P>


<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall <FONT STYLE="letter-spacing: -0.05pt">obtain all such authorizations</FONT> or exemptions thereof,
or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">e)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jurisdiction</U>. All questions concerning the construction,
validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Agreement.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">f)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restrictions</U>. The Holder acknowledges that the
Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">g)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-waiver and Expenses</U>. No course of dealing
or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice
the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Agreement, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the
Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">h)&nbsp;
<U>Notices</U>.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any notice, request or other document
required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions
of the Agreement.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">i)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limitation of Liability</U>. No provision hereof,
in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein
of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any shares of Common
Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">j)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Remedies</U>. The Holder, in addition to being entitled
to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this
Warrant. The Company agrees that monetary damages would not be adequate compensation <FONT STYLE="letter-spacing: -0.05pt">for any loss
incurred</FONT> by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense
in any action for specific performance that a remedy at law would be adequate.</FONT></P>


<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">k)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Successors and Assigns</U>. Subject to applicable
securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors
and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended
to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">l)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amendment</U>. This Warrant may be modified or amended
or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">m)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severability</U>. Wherever possible, each provision
of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant
shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity,
without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">n)&nbsp;
<U>Headings</U>. The headings used in</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this Warrant are
for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</FONT></P>



<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>



<P STYLE="text-align: center; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>


<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS
WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SOCIETY PASS INCORPORATED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: ___________________</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Dennis Nguyen</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO: SOCIETY
PASS INCORPORATED</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(1)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned hereby elects to purchase<U>&#9;</U>Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the
exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(2)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States; or&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>



<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(3)&nbsp;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please issue said Warrant Shares in the name of the
undersigned or in such other name as is specified below:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrant
Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity: _____________________________________________________</I></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: 10.5pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-bottom: 0pt; font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR VALUE
RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: __________, ___</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 8.5pt Times New Roman, Times, Serif"></P>


<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Warrant
Exercise Log</U></B>&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24%; border: black 1pt solid; padding-left: 5.95pt; line-height: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="width: 25%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.45pt; padding-left: 5.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrant Shares Available to be Exercised</FONT></TD>
    <TD STYLE="width: 32%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 6.65pt; padding-left: 5.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrant Shares Exercised</FONT></TD>
    <TD STYLE="width: 19%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 8.75pt; padding-left: 5.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrant Shares Remaining to be Exercised</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SOCIETY
PASS INCORPORATED</B></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
DATED _<U>&#9;</U>, 2021</B></FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
NO. [ ]</B></FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF ASSIGNMENT</B></FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To
be completed and signed only upon transfer of Warrant]</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto __________ the right represented by the above-captioned Warrant
to purchase <U>&#9;_______</U>shares of Company Common Stock and appoints ________ attorney to transfer said right on the books of the
Company with full power of substitution in the premises.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 12pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
  <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature must conform in all respects to name of holder
  as specified on the face of the Warrant)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address of Transferee</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the presence of:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
V<B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF PRESS RELEASE</B></FONT></P>





<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Society
Pass Incorporated.</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________,
2021</FONT></P>



<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Society
Pass Incorporated (the &ldquo;Company&rdquo;) announced today that Maxim Group LLC, the sole book-running manager in the Company&rsquo;s
recent public sale of ____ shares of Common Stock, are [waiving][releasing] a lock-up restriction with respect to ____ shares of Common
Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____,
2021 and the shares of Common Stock may be sold on or after such date.</FONT></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited,
and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United
States Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be attached]</FONT></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"></P>




















































































































<P STYLE="font: 11.5pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><IMG SRC="image_003.jpg" ALT="Logo&#10;&#10;Description automatically generated" STYLE="height: 88px; width: 89px"></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><B>Society Pass (SoPa) Announces Pricing
of US$26 Million Initial Public Offering</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">November 08, 2021 19:00 ET | Source: Society
Pass Incorporated</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center"><I>Common Shares to Trade on NASDAQ under
Ticker &ldquo;SOPA&rdquo;</I></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Singapore, Nov. 08, 2021 (GLOBE NEWSWIRE)
-- via NewMediaWire -- Society Pass Incorporated (Nasdaq: SOPA) (&ldquo;SoPa&rdquo; or the &ldquo;Company&rdquo;), a leading Southeast
Asian data-driven loyalty platform, today announced the pricing of its initial public offering of 2,888,889 shares of common stock (the
&ldquo;Shares&rdquo;) at a price of US$9.00 per share. The shares have been approved for listing on the Nasdaq Capital Market (&quot;Nasdaq&quot;)
and will trade under the ticker symbol &quot;SOPA&quot; beginning November 9, 2021.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">The Company has granted the underwriters
a 45-day option to purchase up to 433,333 additional shares at the initial public offering price to cover over-allotments, if any. The
offering is expected to close on November 12, 2021, subject to customary closing conditions.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Maxim Group LLC is acting as sole book-running
manager for the offering.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">A registration statement relating to the
Shares was declared effective by the SEC on November 8, 2021. The offering is being made only by means of a prospectus, copies of which
may be obtained by contacting Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, New York 10022. Copies of the registration statement
can be accessed through the SEC's website at www.sec.gov.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">This press release shall not constitute
an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><B>About Society Pass</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">SoPa&rsquo;s customer loyalty and analytics
platform has onboarded hundreds of thousands of registered consumers. SoPa provides merchants with SoPa.asia &ndash; an online commerce
platform for users, alongside with #HOTTAB Biz &ndash; a convenient order management app for business partners on SoPa.asia, and #HOTTAB
POS &ndash; a specialized POS technology solution, a comprehensive system for payment, loyal customer management, user&rsquo;s profile
analytics, and convenient financial support packages for small and medium-sized enterprises. All tools offered above will allow businesses
to attract and retain customers through personalized interaction based on analytics with a high profit margin. SoPa also operates www.leflair.com,
Vietnam&rsquo;s leading lifestyle e-commerce platform.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">For more information, please check out:
http://thesocietypass.com/</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">The information contained herein may contain
&ldquo;forward-looking statements.&rdquo; Forward-looking statements reflect the current view about future events. When used in this press
release, the words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;future,&rdquo;
&ldquo;intend,&rdquo; &ldquo;plan,&rdquo; or the negative of these terms and similar expressions, as they relate to us or our management,
identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating
to the view of management of the Company concerning its business strategy, future operating results and liquidity and capital resources
outlook. Forward-looking statements are based on the Company&rsquo;s current expectations and assumptions regarding its business, the
economy and other future conditions. Because forward&ndash;looking statements relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict. The Company&rsquo;s actual results may differ materially from those
contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance.
We caution you therefore against relying on any of these forward-looking statements. Factors or events that could cause the Company&rsquo;s
actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot
guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities
laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to
actual results.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Contacts:</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">SoPa:</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Raynauld Liang, CFO</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">ray@thesocietypass.com</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Investor Relations:</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Jeff Ramson, CEO</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">PCG Advisory</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">jramson@pcgadvisory.com</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">(646) 863-6341</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sopa-20211108.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6kps7xRiXgOn8uAaHpcWa6IKbOdzpB6WYkxtGx9bTm6Xy8n58KyvCspzcjWIREJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:SOPA="http://thesocietypass.com/20211108" elementFormDefault="qualified" targetNamespace="http://thesocietypass.com/20211108">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://thesocietypass.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="sopa-20211108_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="sopa-20211108_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sopa-20211108_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sopa-20211108_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thesocietypass.com/role/Cover" xlink:href="sopa-20211108.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://thesocietypass.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+#!D2$P\4'1H?'AT:'!P@)"XG
M("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_VP!# 0D)"0P+#!@-#1@R(1PA
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C+_P  1" !8 %D# 2(  A$! Q$!_\0 '  !  (# 0$!
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M+GGDT?,J01Z#R89NZ6L#Y;G[*?TXHX*D3(6-:P-&P:-@MA<+.0L<O+T1*Q^
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M-/SLK'V:N1? &L8UHC  W:-NNQWYE6"H9V>Z*FT31R566^+OM5MT[9"TAVQ
F'XO-W+F5,USGKQ=#9;UU"(BU,A$1 $1$ 1$0!$1 $1$ 1$0'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ex99_2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_004.jpg" ALT="Logo&#10;&#10;Description automatically generated" STYLE="height: 88px; width: 89px"></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Society
Pass (SoPa) Announces Closing of $26,000,000 Initial Public Offering and Closing of $2,125,000 Over-Allotment</B></FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
12, 2021 16:05 ET | Source: Society Pass Incorporated</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore,
Nov. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Society Pass Incorporated (Nasdaq: SOPA) (&ldquo;SoPa&rdquo; or the &ldquo;Company&rdquo;),
a leading Southeast Asian data-driven loyalty platform, today announced the closing of its initial public offering (the &ldquo;IPO&rdquo;)
of 2,888,889 shares of its common stock (&ldquo;Common Stock&rdquo;) at a price of $9.00 per share and its closing of the underwriter&rsquo;s
purchase of an additional 236,111 shares of Common Stock pursuant to its over-allotment option, each occurring on November 12, 2021.</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock began trading on the Nasdaq Capital Market on November 9, 2021, under the symbol &quot;SOPA.&rdquo;</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received aggregate proceeds of $28.125 million, before deducting underwriting discounts and commissions and other estimated offering
expenses.</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maxim
Group LLC acted as sole book-running manager for the IPO.</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IPO was conducted pursuant to the Company's registration statement on Form S-1 (File No. 333-258056), as amended, previously filed with
and subsequently declared effective by the Securities and Exchange Commission (&quot;SEC&quot;). A final prospectus relating to the offering
was filed with the SEC on November 10, 2021. Both the registration statement, as amended and final prospectus are available on the SEC's
website at http://www.sec.gov. Electronic copies of the final prospectus relating to this offering may be obtained from Maxim Group LLC,
300 Park Avenue, 16th Floor, New York, NY 10022, at (212) 895-3745.</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About
Society Pass</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SoPa&rsquo;s
customer loyalty and analytics platform has onboarded hundreds of thousands of registered consumers. SoPa provides merchants with
SoPa.asia &ndash; an online commerce platform for users, alongside with #HOTTAB Biz &ndash; a convenient order management app for
business partners on SoPa.asia, and #HOTTAB POS &ndash; a specialized POS technology solution, a comprehensive system for payment,
loyal customer management, user&rsquo;s profile analytics, and convenient financial support packages for small and medium-sized
enterprises. All tools offered above will allow businesses to attract and retain customers through personalized interaction based on
analytics with a high profit margin. SoPa also operates www.leflair.com, Vietnam&rsquo;s leading lifestyle e-commerce
platform.</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please check out: http://thesocietypass.com/</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward
Looking Statements</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained herein may contain &ldquo;forward&#45;looking statements.&rdquo; Forward&#45;looking statements reflect the current
view about future events. When used in this press release, the words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;future,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; or the negative of these terms and similar expressions,
as they relate to us or our management, identify forward&#45;looking statements. Such statements include, but are not limited to, statements
contained in this press release relating to the view of management of the Company concerning its business strategy, future operating
results and liquidity and capital resources outlook. Forward&#45;looking statements are based on the Company&rsquo;s current expectations
and assumptions regarding its business, the economy and other future conditions. Because forward&ndash;looking statements relate to the
future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company&rsquo;s
actual results may differ materially from those contemplated by the forward&#45;looking statements. They are neither statements of historical
fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward&#45;looking
statements. Factors or events that could cause the Company&rsquo;s actual results to differ may emerge from time to time, and it is not
possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance or achievements.
Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of
the forward&#45;looking statements to conform these statements to actual results.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contacts:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SoPa:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raynauld
Liang, CFO</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ray@thesocietypass.com</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff
Ramson, CEO</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCG
Advisory</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jramson@pcgadvisory.com</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(646)
863-6341</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+#!D2$P\4'1H?'AT:'!P@)"XG
M("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_VP!# 0D)"0P+#!@-#1@R(1PA
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C+_P  1" !8 %D# 2(  A$! Q$!_\0 '  !  (# 0$!
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M+GGDT?,J01Z#R89NZ6L#Y;G[*?TXHX*D3(6-:P-&P:-@MA<+.0L<O+T1*Q^
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M-/SLK'V:N1? &L8UHC  W:-NNQWYE6"H9V>Z*FT31R566^+OM5MT[9"TAVQ
F'XO-W+F5,USGKQ=#9;UU"(BU,A$1 $1$ 1$0!$1 $1$ 1$0'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>sopa111021form8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sopa-20211108.xsd" xlink:type="simple"/>
    <context id="From2021-11-08to2021-11-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817511</identifier>
        </entity>
        <period>
            <startDate>2021-11-08</startDate>
            <endDate>2021-11-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-11-08to2021-11-08">0001817511</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-11-08to2021-11-08">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-11-08to2021-11-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-11-08to2021-11-08">2021-11-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-11-08to2021-11-08">SOCIETY PASS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-11-08to2021-11-08">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-11-08to2021-11-08">001-41037</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-11-08to2021-11-08">83-1019155</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-11-08to2021-11-08">701                                             S. Carson Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-11-08to2021-11-08">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-11-08to2021-11-08">Carson     City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-11-08to2021-11-08">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-11-08to2021-11-08">89701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-11-08to2021-11-08">65</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-11-08to2021-11-08">6518-9382</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-11-08to2021-11-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-11-08to2021-11-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-11-08to2021-11-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-11-08to2021-11-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-11-08to2021-11-08">Common     Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-11-08to2021-11-08">SOPA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-11-08to2021-11-08">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-11-08to2021-11-08">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-11-08to2021-11-08">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139766649162312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  08,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SOCIETY
PASS INCORPORATED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001817511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-1019155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">701
                                            S. Carson Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Carson
    City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6518-9382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SOPA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ &HML4P=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M"  :BVQ3HHR6Y>X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    "  :BVQ3F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !J+;%,T
MR]'?A00  +L1   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    "  :BVQ3GZ ;\+$"  #B#   #0
M    @ '(#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( !J+;%.7BKL<P
M !,"   +              "  :0/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M !J+;%.JQ"(6,P$  "("   /              "  8T0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  :BVQ3)!Z;HJT   #X 0  &@
M@ 'M$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  :
MBVQ399!YDAD!  #/ P  $P              @ '2$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"   <%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="sopa111021form8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thesocietypass.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="sopa111021form8k.htm">sopa111021form8k.htm</File>
    <File>ex1_1.htm</File>
    <File>ex99_1.htm</File>
    <File>ex99_2.htm</File>
    <File>sopa-20211108.xsd</File>
    <File>sopa-20211108_lab.xml</File>
    <File>sopa-20211108_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sopa111021form8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "sopa111021form8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sopa-20211108_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sopa-20211108_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sopa-20211108.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SOPA",
   "nsuri": "http://thesocietypass.com/20211108",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "sopa111021form8k.htm",
      "contextRef": "From2021-11-08to2021-11-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://thesocietypass.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "sopa111021form8k.htm",
      "contextRef": "From2021-11-08to2021-11-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thesocietypass.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001607062-21-000528-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001607062-21-000528-xbrl.zip
M4$L#!!0    ( !J+;%,$VQ$BY!,! )F$!@ )    97@Q7S$N:'1M[+UK<]O6
MTB;Z757Z#YC,NW=)59 B^9*;,ZF2+\EVG<3QV,[.[)J:#R )2HA)@ % R<RO
M/WU=JQ>P0%&VZ$AZ=:;.NV.1!-:E5Z_NI[N?_OY?[W[Y^8?=G>__]>+D.?QO
M@O_?]^]>OOOYQ0_??\G_"Y]^*1]___37Y_])WK[[S\\O_M<7TZILOTN.CQ9M
M\JZ8YTWR*K](WE3SK$SY#VGR-J^+Z1?P0WAR^'_P_WW_NO.H!Y<_ZOLO7_\0
M_G:>U:=%>3"JVK::?Y? <)XD_+Q1-9O00[\\_N:K?ZQ_\I.DS3^T!]FL."V_
M2\9YV>8UO.W'7U^]LX,\F&;S8K;Z[K*'T7>;XJ^<%^B+'][^^NSEBW?_V=UY
M??+V;?+RU;-?W[S^]<W)NQ?/O_\27W)K)_;]TQ]^>_7\Q9O?W[Q\]_+53[L[
M)S^]>?'BEQ>OWGW_Y=,?!B=G!U47IV=N;L?'&PC!M8W^576>ST=YO;OS39H\
M.'IPV6:TU4)V8GAW+I]!N">S?-I>YYQ^.?D_+W_9W?GIS:^_O4Y^_OG9X)PV
M'^Y&L]_FG!X>'<'1R>KWR<EY7B[S-#G^JCU+?IQ557T7Y@??W-WY3U6_3Y-7
M_X&_'3T(1=$KSD]1FO$'W(;U^?[E#R?-[LZ;?%'G#>BPK"W.\Z2:)NU9GOQ6
M3O+ZHBY LS7??_ER6.G<K@F7V3R?[.Y49?+];S^\'9_ED^4L3UY^_^5O/R1G
M>9VWU2:3W>!ZOM91_[,<-8LGFXQL$\&]MI']G$V*'"0H*R?)3R! LWR>E]]U
MAOB1!RR4A#^635M,5]<Y^'=G^>[.$J6\@5?D$_AF-2[R=I6\SIHF>5F.JWI1
MU5F+'V7PX/-LDB7ZQP(D: _/R3]GDS^7U1.XL9]5\T56KO"&_F=-?]Q/2:9&
M*_A9.2WJ>9,4;9-DIW6.*]7B$PI8/_^,$_W(/B5IJZ1HFF6>X$(W^6R&?\&7
M+_TA3:K:_A,FGC7TG7'6Y'#25LD(%#R)?U*4B1=]$?O=G;T\&Y_!STHS)Z,%
MS(AP'"G,:3;+QZ@S9JLT"=<BU!Y/?WCB5V0* [TXJ^;)+]F'8I[\5%?+!=ZH
M,,4D@\>5IR!035*'6FD/QMPLQV<PG44V+MK>&T,M%F["WLD^3BL[A=4]A0U%
M'?<@_>:;;^#__S9ISC+X)?YM7,WGL*]-6XW?I[ @X1M^A U,WM*7@]U99'5R
MGLU@>_[KZ/#HZ.@X6<!VT%-5F8IH)'N!M."[WN*[@L?A'N\]A?]M\:>[.SDM
M,GQ5GA5.-$U@]4 :<'J328%?S&;)HX</TX</'YFIV==U!??7!3V_-[64QM)6
MISE\'ZRYBP*L _RI68GN-O37YS"!DP9#F,(Y+$]9A+.96QK^ 1Z0-I\O9GC<
M$C@P># 2=QI0-NH<GE"C\H;IHLR"1(B(FZG(:\P #COZ:&MWU_4IIR=XMJKZ
MN^1_'H'5<G3TQ0_'A^@P\CRN[V*!&S ?+^&4@A9_DOQZGM<')[-9U=*2LU3@
MQ=A?P4^P>N):_1.LBJU>$]V=> (V20M*[:!!+52>?I<<P)E_C*NYE^WS-;V=
MG7J]K,=GJ,KAW 2:"/8G^;6D<S#*FJ*1@[6[8S5H539T\BZRNLY*W&\]0GCP
MLH+NO]&R!1T[^@/TC5XP,-4Y_Q*^Q^K%_;+)6U3F[5D:Z#BZW1IW9[%U8"^M
M)@=! R7U6W!;R5]G*WI;6;7)'U4!)L4J[:ENU6YF&5!;9LE"UVA1%V/ZZG]]
M<_CPP6-4R+L[_NMP_Q1PE;@%@I\G7Q\^_D<R*9IQM2S=]!?+T:P8>^7%ST7U
M;A[6T:9NHU[CEX.+:"/+Z#:)_&A[(O^NXX.LEQ"4N02-&"<"TQI,#"N7^-_E
M$G&)SA'R@IQ4BT75P.OPRT4- M(LV,(APPF.5LQMR-HVP[^((86CV]V99Y,<
M)3*K6_I[->UJT=N_^^/M*KQL1?<0;O;S? :;4*]8V^F_Z*.%? TV$"R#T#A!
M^P?TS@CM7]R.%I[^W=%1DAW.#U,:#:(#20MC27%O63NAIDN>+AM0BN '/ ?+
M>0J6;G6!"@"_D8,V8*&8H$+J'/\7^NGNSG/X.##MG 5W6C2M.!%O03V+,Y"I
M:LVF:-!/\BGJY?UD#RQF4L9G1;UV9.[=";XZ30JY"09>"'?%)!_/8*4F9E+\
M\D??/3Q*%K!.X3+MHYN1M6R*YUD]*^"[^ &:8FZUZ3A.P#*%UXU6$:N5+X7@
MUB!K%S4M*,TF;NO:=U=HDB9@+XZO^.JD\V8PK%#5G%7+FCZ:R"4S&1"RK@&,
MJSB&E^>3CBGZ; :J!#9&I>!0G2=\W5@^E'G*\W=W]-_A10:O95O<#0J=E;R&
MHU^,X?'&6X*'IK$AJO6<K#&>9<1VL(@/#D\]/%YR@.R\<0LN"K@C0?C*!D:
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MQ8S\;%7YSW,R-5%;O:MA_!XC"I7R\W?/K T!8U%-G(W95XD ]HRY1%5U3;9
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MA/-\LXP=4E6^N+J:6G8[G_V'\S.)X-*QFN*F=9XU8,R,9M*C&V>C#(V4*4X
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MS0)32MQ&W8;:KJ;95FW7B[<OWOS[Q?/#:RKNVNHJM.TM687/CV MES>%&5J
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MPV]X?]=!XN9MYJ]P6.$1PJR%</U4VUB[%5I',)>NS;73Y>95] \<FT3>@5)
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M19*A]77!](Z$$]]=$&T EPNCU[P=O$L<*/A(\4<T#GO.DP^/APZSB(I%X2G
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M@NWN#*P8)]M=LES:) 'QN?W(52^E:=HV?1VRX$@"J!H2#QBW%S(/Q6:H9+R
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MP7W7=VJ"C-]!WI_,5$AO>?'VV5?9;%FQJRXFVU%*EJPC-]1EXU+A-2KWB E
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MP3V&I40:P9*>5/ @;.ICREB22[#H+RF9TZEH&8/C3]^PV;#+@-<T-%W4#0^
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MMO0ZA6)+UA@#1W?CH -*H;1;9OHL3-M8:.BOJ7A/>R_A0,P0C"<MS =":_;
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MM%"A8?O1++3<1<78;J*;=#O8VFF?;OT$+[KD/@*F^03H)ZX%Y$'@QOU65G^
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M@4(\0MEXNM!<->B+J5$/0Y$6EH@?L5/"G)P7P5W99"V*M'*H,W3ELE5K_*?
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MZ3H*ZH]:4/?K.FTL<>5A;&1V([-V#<"7=:1;AX+SAQNW%7"^[V#(*DD:>YN
MZEH$5/<V =5U"O\]IE#E_O'QX;\"=?+K.=IW934E#B0IEC --N\2W5Y:U-U=
MXO+]EX#9Y^)^[^G.T]W%*<$KW"'?)Q5)"JE#Q=&/A%AF;^=YO_<A_0P^:5,6
MT?Y-6LS2QS<-^&2_)^U??X/?[?ZX=V]9YFN0Z?K#3Q^2<9;6W/;]9SB+.2J+
MK^_8\> ,W1?839BIMS/J1&]HN&LFU*8S9/@%HBVDA9->PJ ,7>HY5(K25'B
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M!LVMU+O%#OJFLJ;9%VPHJQ3;127*09>3(&*NTBE(D%JVI=>)^E1&T.^9ZO]
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M33UO0U/;HHQLFKJ4H]J[O:9X4)9:UA\?CH2,N7P@L2D+IH9NK38#=2"W"/,
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M0P'NE]=7^<C:VA8KR'=67#B.KU9SS3:GN9 U430#,*J1?:^*VZF"7,5002&
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MK^!76.&AJ\KN/;%0-\N,D^"=5R77^PK;?XH 7B]_%JQ/M1Q:S']H6\Y8S,Z
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MJ]EB,5LLU=>Z%^O$4MED=S R.A%Z9F#! 9!& 0J>^)V034X8@JB/$@PET@Q
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M=8U&'[X_^@\&$-Y<O'M[\/]02P,$%     @ &HML4\#XGM'E"0  T1X   H
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M.#K<VSG<V^\\TI?^5*?Z$YW3W>JO>OX#4$L#!!0    ( !J+;%/##8D -@,
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MGP)9I60OAQ7*^I=_MTO)6,F%J)^!5Q1'\;_$H8%L+XV&G6C*Y1]02P,$%
M  @ &HML4]G'I^K]"@  @(8  !4   !S;W!A+3(P,C$Q,3 X7VQA8BYX;6S-
MG5UOX[@5AN\+]#]PW9L6&,=Q@A9(=F87&4^R,#:;9&//;-M%L: EQA%"DP$E
M)_:_+RF)LD3Q2$J*DIR+&8_X'NJE^)BDOHX__KC;4/1"1)IP]FDT/3H>(<(B
M'B=L_6GT=3&^6,SF\Q%*,\QB3#DCGT:,CW[\X<]_0O+/Q^_&8W25$!J?HR\\
M&L_9 _\>W> -.4<_$48$SKCX'GW#=*NV\*N$$H%F?/-,249D0;'C<_3WH^GQ
M"HW' ^K]1EC,Q=?[>57O8Y8]I^>3R>OKZQ'C+_B5BZ?T*.*;814N,IQMTZJV
MX]UQ^:<(_T@3]G2N_EKAE"!YO%AZODN33R.UWW*WKZ='7*PG)\?'T\D_?[E>
M1(]D@\<)4\<M(B,=I6JQQ4W/SLXF>:F6MI2[E:!Z'Z<3;:>J698F'?J:DS0Y
M3W-[USS"6=[MO;M!H$+];ZQE8[5I/#T9GTZ/=FD\T@<_/X*"4W)/'E#>S/-L
M_RQ12A-%PJC<]BC(@]T,%6*BXB>,K'%&8K6C,[6CZ3_4COY2;K[&*T)'2"DE
M'V"[SAIUE4$3UV;OB$AX?,G>Y]J,]F1??G=$]C\TH![OO E+GF'Z+O/U2.>V
M;\C[CO@ASOV1EN,\>=^1KD7^7VQG;<MO/KSVXTK5QFOYJ6&1[#(Y@9%8FU15
M=(S ^1[RB:&LNZJ=1XUZJ1K-N6BW7<V,>9TIB8[6_&42DT36?3)5'\;J0]YL
M^9\_9ERN!"Y6:29PE.F:\F9\&EG*)Z8EI;P0VA<644_C2L4DXG)J>L[&M#B,
M1?B#X!OK;LM6<TOA'W15Q1>'1>X",-J0"9+RK8C(FWJE[A8Z2J6C#94*M:0B
M;/QU,?HAUZ#?M>H_'R>'6AQTM%P";3>$94M9HZ4%S6)7W6PSI7NY7A9$)UL,
MF7VL)4AI''?PA=QQK'9^1?':8M\H=]7%5ENZCQN%072RS9'9RY4&*9&O;OY"
MTD@DSVHYW]6.ALQYIUM,MOJ^I@D+@;8QF(2:UM/ ?D_6B9I:E 5U?DO4QHYA
M#-"['OH[;9MS@54<!#1#'(*S13T(55&>.+I@;(OI/7GFH@N?ILPU-3:3)BQU
M35",6(R!:!1:5(@]$?'K5IZQ$T'WO5"TE*ZY *R::!BRH.BP>P,!J>1^&5D*
MS-)$#6"]D+2ESD\W +.M4P]#%Q0G@#GXE*32^R5E\4@H5?<#,.L?4&QBU[3
MADU>VLJ@B 'M@<SD$:@,"0>;RQ>U.I?+I(&-K>E]PM.RW<5/)0X6(=/A0(KR
M,*3B/)%4NPW1PU!+Z9H>P*K)C2$+BAB[-Y"50HYRO7](+ED\")%*YP<0PZ8=
MCU(4(!Q-9WUH2+5/,*Z2-,*T\'(EMZ4=S;-H70,"VC4A:0F# @5R!\)2!&AF
M\A"OP/R+8#$,EYK2#RPMJW94*EF H)C>^C!1>B^0S+9"-%S#,PXL=793ML=L
M=7\6T 4!2H^YUEW;0MX Q=,,=,FR)-NKY^ENMIL5$9;&M26NV(#,:2;,\B!8
M $R9#!0RI'2H$'KI>7V7@&7J(4:P.:;,+0%VDTT*FIJ 2+ : V@X:/-G2KT0
M,9,CD\!TSF*R^YGLP7:U=&Z9 &PVH3!$ 5%A=P9@48I1KD92[@6,.Y%LL-@O
MDJAGJF@+W:(!&6VR8:H"@@.P!M!1JM%B/O,YDRSQ;AY+4).'I'@>O(<24.\6
MEA[;368 <4#H=#L$"))!J!GE$Z0YB[AXYK7''69\*P? _8S'\ JE)\HM5(.:
MT$2K,R0@P(;X!#!KA'XHGDE!7+W'DU> 5 U>B+N(8WF@TO*?ZX21*=A^J]8M
M71UVFTQ9A &1!+L#^"F5'_0'I&+0+0L%FI,W-/7$/S0G0Z$Y"1J:D_= LWSE
M@4!S^H:FGOJ'YG0H-*=!0W/Z+FADQWL=:V;RXZU8\E?;P]F@T@LR;:M68 ZR
M\'!I>>N#106H]8P*\8E)OK"Z%7>"OR0L@I?,D-P+,(!I*S6&-CQT[ ;[^*D6
MQ#K.ZUA3+,I[OR1:YF>4:9JT#S&%)CQ(FL9Z!Y="[1.).YYFF/X[>>X\$;>+
MO>!A-6R%I*$,#Q6;O3Y@BA@D@WR<6)>XJAL:UE?)C')WKP!;;!U> :X5!@&!
MS5'[%>#BZDDA<MW-BE%!,# B-(N==;+%5-7'M;(PNKAMJ-7#^?=::GQ\D55V
M%WKWR!G\@$!;XJJG(7.ZM\WR('H<,&7V>BY#N<[3U7B582*U#]^U,F<SNVFG
MFLAU01"]:[II3=.ZW'%O_B:23.YYQC>;+2OO\MB>&P1TKGJYTZ;N<:LHB-[O
M<F:24&I14^P8BP6G291D"5O_(D\^18)MK;*)7 $!&]0TM!5!H #:,CDX")%6
M.H;@3A %(9$=D;\$J!(+B=N'!^MLWR5V!46_80T'K P"DEY[)BPR8!S5(E 1
M@O(8O]C,TW1+Q)O@L81X0@@T#X#4TH>($V2R%ZHBT"=;"Q)MY?RXGYZLEDE&
M;2>7;8FS.0DP5\U(1GD0; "F3!;R,L0?T/3DKZN_(1WEN/MO^%)@E3QVL=^L
M. 6R3UE5KB#HL*@YL$B"0 'V9=)PPU$I18761W:JAEE+<XQR5P!8;>FN;Q0&
MT>DV1ZTO?Z.O/0WYE[OH49HBP L)=IGKH=]FTAS^ZYH@$.@PUCHI*:5(:WV\
MD'"8LM;]BX"UMT7 NF<1L YQ$; >N@A8>UL$Z-T6*4+DN'2[HLD: \D).]6N
MH>BP;/)AD0:%"NP/'#.J$'2(<9W1,D]QIM+SBTV^_ROYP=)*0.<LIV67S2JI
MI4T4!"-=SEII+8ND<S4Q4FK77&SC)"-Q8>8J89A%":95>D3;%?'^$&>T##1?
M@=.C#X.A829;.!5A.I=A%7A(=>GZ4GKQ ,9OA-*?&7]E"X)3SDA<7$NQW2GJ
MUKM]8J;'=O.A&4 <!$Y#' */SJB@\9.*0CJLO!+FA:1OG&Y9AD7^+KFPC4R
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M[!SINK,'W+MJBV_<+_<^5GOD?U!+ P04    "  :BVQ3")FC69$8  #@K0
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M&AM3,%JXMT<1D8D27]U"5VE^Z4?8R($P<+-EVG!78-S.QO)4D5L:HP1%G8+
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M8 ]W&A>GM9M[GQW_#U!+ 0(4 Q0    ( !J+;%,$VQ$BY!,! )F$!@ )
M          "  0    !E>#%?,2YH=&U02P$"% ,4    "  :BVQ3P/B>T>4)
M  #1'@  "@              @ $+% $ 97@Y.5\Q+FAT;5!+ 0(4 Q0    (
M !J+;%,A#\7ZD H  -XC   *              "  1@> 0!E>#DY7S(N:'1M
M4$L! A0#%     @ &HML4\,-B0 V P  _PL  !$              ( !T"@!
M '-O<&$M,C R,3$Q,#@N>'-D4$L! A0#%     @ &HML4]G'I^K]"@  @(8
M !4              ( !-2P! '-O<&$M,C R,3$Q,#A?;&%B+GAM;%!+ 0(4
M Q0    ( !J+;%/OV'<+60<  .%7   5              "  64W 0!S;W!A
M+3(P,C$Q,3 X7W!R92YX;6Q02P$"% ,4    "  :BVQ3")FC69$8  #@K0
M%               @ 'Q/@$ <V]P83$Q,3 R,69O<FTX:RYH=&U02P4&
/  < !P"N 0  M%<!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
